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ABSTRACT
Oxidative  stress  has  been  proposed  to  play  a  cardinal  role  in  the
aetiology and pathogenesis of Alzheimer’s disease (AD). Therefore,
antioxidants have been studied for their therapeutic potential in AD
therapy. However, there is still a need for novel sources of antioxidants.
Recently, there has been an increased interest in aromatic and
medicinal plants as sources of natural antioxidants. The plants
Dracocephalum moldavica L.  and Melissa officinalis L., which belong
to the family Lamiaceae, have been used in Iran for their culinary
usefulness and medicinal properties. Therefore, extracts of the plants
were screened for antioxidant properties in a battery of in vitro assays.
The plant extracts demonstrated a wide range of antioxidant activities.
Furthermore, because it was important to determine which
constituents present within the extracts may contribute to the observed
activity, compositional fingerprint analyses were carried out using
HPLC-PDA techniques. The extracts were found to contain
polyphenolic compounds such as hydroxylated benzoic and cinnamic
acid derivatives and flavonoids. Rosmarinic acid was the most abundant
constituent in both plants.
The plant M. officinalis has been used since antiquity in the
treatment of cognitive dysfunction. The plant was recently assessed for
its clinical efficacy against AD and was found to be effective in the
management of mild to moderate AD patients. According to a review
carried out by the author, screening of medicinal plants for bioactivities
relevant in the treatment AD can provide useful leads in the discovery
of drugs against AD. Therefore, in addition to antioxidant evaluation,
M. officinalis was screened for another bioactivity relevant to AD
therapy, viz. acetylcholinesterase (AChE) inhibition. The plant extract
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showed AChE inhibitory activity, which formed the basis for activity
guided fractionation.
 The extract was fractionated using semipreparative scale HPLC
fractionation. Fractions were subsequently subjected to AChE inhibitory
screening. Most of the fractions demonstrated inhibitory activity and
were proved to be significantly (P < 0.05) more potent than the crude
extract. This is an indication of the complex nature of potential
interactions between various components within the extract. The
contents of the most potent fraction were tentatively identified as a
mixture of cis- and trans-rosmarinic acid using LC-DAD-MS and NMR
techniques.
There is a need to further investigate the efficacy of these chemical
constituents in in vivo AD models. The remaining potent fractions
should be analysed further to determine the identity of their chemical
constituents and the possibility of a correlation existing between
antioxidant activity and AChE inhibition should be investigated.
The current study showed the multifaceted nature of antioxidant
action of D. moldavica and M. officinalis. Furthermore, the latter
demonstrated AChE inhibitory activity. A review of the potential
benefits of ethnopharmacological screening of plants in AD therapy was
made and the importance of bioactivity guided screening and
fractionation of medicinal plants was highlighted. It can be concluded
that M. officinalis is a potential source for discovery and development
of drugs against AD.
13
1. INTRODUCTION
Alzheimer’s disease (AD) is a progressive, neurodegenerative
disorder characterised by impairment in learning and memory followed
by more global cognitive deficits and behavioural disturbances (i.e.
depression, agitation and psychosis), which becomes progressively
more severe. Due to the debilitating nature of the disease, an enormous
social and financial burden is placed on society. The significance of AD
is further compounded as the prevalence is expected to quadruple by
2050 (Brookmeyer et al. 2007). Currently there is no cure for the
disorder and much of the treatments available have been able to only
delay the progression of the disease or provide symptomatic relief for a
short period of time. Therefore, there is a need to discover novel
molecular templates for effective drugs against AD.
Plants may be the answer as they have been used in traditional
medicinal systems for the treatment of cognitive dysfunction. The
strategy used for the discovery of new drugs based on the screening of
plants having medicinal uses relevant to the treatment of a particular
disease, is referred to as ethnopharmacological screening. This approach
has been rewarding as it has resulted in the identification of compounds
which are currently either in clinical use or templates for further drug
discovery, e.g. galantamine (Houghton et al. 2005), huperazine A
(Houghton et al. 2005) and PHY (Orhan et al. 2006).
One of the pathological hallmarks of AD is oxidative stress and
antioxidant therapy has been one of the major lines of pharmacological
intervention studied in the treatment of the disease (Dastmalchi et al.
2007a).  Therefore, there is a search for novel antioxidants with
emphasis being placed on medicinal, aromatic and edible plants.
Plants belonging to the family Lamiaceae have been used in the
Mediterranean region and South West Asia because of their culinary
usefulness and medicinal properties. Many of these plants have not been
14
investigated fully for their antioxidant activities. Very often plants exert
their effect via a variety of different mechanisms, this is especially true
in the case of antioxidant activity (Houghton et al. 2007). Therefore, in
order to characterise the antioxidant properties of the plants, they are
often screened in a battery of in vitro assays.
Another bioactivity of relevance in the treatment of AD is AChE
inhibition. Screening of plant extracts and fractions thereof for this
activity has resulted in the identification of AChE inhibitors which are
currently either in clinical use or templates for further drug discovery
(Dastmalchi et al. 2007a). Therefore, AChE inhibitory guided
fractionation of Lamiaceae plants, with known antioxidant properties,
may have the potential of providing interesting leads in AD drug
discovery and development.
15
2. REVIEW OF THE LITERATURE
2.1. Oxidative Stress and Antioxidants
2.1.1 Oxidative Stress
When living organisms first appeared on Earth, they did so under an
atmosphere containing little oxygen (Halliwell 2006). Early life was
therefore anaerobic, however, later on the oxygen content started to rise
due to the evolution of organisms capable of photosynthesis. They
evolved to use sun energy to split water, thereby producing oxygen. As
a result of the increase in the oxygen level, most anaerobes did not
survive, however, the remaining organisms either retreated to anaerobic
environments or adapted antioxidant defences to protect against oxygen
toxicity. The later adaptation proved to be a useful path to follow,
enabling organisms to utilise oxygen for efficient energy production,
employing electron transport chain with oxygen as the terminal electron
acceptor. This was needed for the evolution of complex multicellular
organisms which have developed systems for delivery of oxygen
throughout their bodies.
Any molecular or atomic species containing one or more unpaired
electrons is called a free radical (Halliwell 2006). By this definition,
even molecular oxygen is a free radical by containing two unpaired
electrons. During the course of normal cellular metabolism, oxygen is
reduced resulting in the generation of reactive intermediates, known as
reactive oxygen species (ROS). These include oxygen radicals and
related non-radical species such as H2O2. The term reactive species has
also been expanded to include reactive nitrogen species (RNS).
ROS and RNS are produced in low to moderate concentrations
during normal physiological conditions and are known to possess
various physiological roles ranging from cellular signal transduction to
defence against pathogens (Valko et al. 2007). However, if there is an
overproduction of ROS and RNS, oxidative and nitrosative stress will
16
occur, respectively. These phenomena may occur when the generation
of reactive species in the biological system exceeds its ability to
neutralise them (Valko et al. 2007). The excessive formation of reactive
species results in the degradation of cellular components, viz., DNA,
carbohydrates, proteins and lipids. This will eventually lead to cellular
dysfunction and ultimately cell death. That is why oxidative stress has
been proposed to play a cardinal role in the pathogenesis of many
diseases such as atherosclerosis, diabetes mellitus, certain types of
cancer and neurodegenerative disorders such as AD (Dastmalchi et al.
2007a; Valko et al. 2007). Furthermore, ROS contribute to the
deterioration of foodstuffs (Sasaki 1996), cosmetics and pharmaceutical
preparations (Branen and Davidson 1997).
2.1.2 Antioxidants
The term antioxidant has been widely used, with its definition being
different depending on the field of study. For example, a polymer
chemist will define an antioxidant differently from a food technologist.
However, a broad definition was suggested by Halliwell and Gutteridge
(1995) as “any substance that when present at low concentrations,
compared to those of an oxidizable substrate, significantly delays or
prevents the oxidation of that substrate”. Therefore, based on this
definition, only substances capable of protecting biological molecules
from oxidative stress can be considered as antioxidants.
A recent literature search performed on the ISI® Web of Knowledge
search engine (Thompson Reuters 2008) indicates there has been an
exponential increase in the research done on natural antioxidants in
particular plant derived antioxidants from aromatic, medicinal and
edible plants. It has been suggested by Dastmalchi et al. (2008) to be
due to three reasons: (i) numerous clinical and epidemiological studies
have demonstrated that consumption of fruits and vegetables is
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associated with reduced risks of developing chronic diseases such as
cancer, cardiovascular disorders and diabetes; (ii) safety consideration
regarding the potential harmful effects of the chronic consumption of
synthetic antioxidants in foods and beverages; and (iii) the public’s
perception that natural and dietary antioxidant are safer than synthetic
analogues. The result has been increased interest in aromatic and
medicinal plants as sources of natural antioxidants.
2.2. Alzheimer’s Disease
2.2.1. Background
A reduction in birth rates and increased life expectancy has resulted
in a quantitative increase in the mean population age. There has also
been an increase in the incidence of age-associated diseases, e.g. cancer,
cardiovascular disease, neurodegeneration, etc. While the aetiology and
pathogenesis of many age-related conditions may be affected by
lifestyle changes or can be managed through pharmacological
intervention, neuro-degenerative disorders are either poorly responsive
to such approaches or their progression appears unabatable. Of the
neurodegenerative disorders, AD is considered to be responsible for ca.
60% of  all  dementia  in  people  aged  65  or  older  (Francis et al. 1999).
Due to its debilitating nature, an enormous social and economic burden
is placed on society. The significance of AD is further compounded as
the number of identified cases is estimated to quadruple by 2050
(Brookmeyer 2007).
The pathology of AD is a multifaceted one with several pathogenic
pathways believed to contribute to the progression of the disease, viz.,
senile plaque deposition, neurofibrillary tangle formation, inflammatory
cascade, oxidative stress and cholinergic deficit (Small and Mayeux
2005). Based on these pathological hallmarks, several lines of
18
pharmacological treatments have been investigated, two of which are
discussed in the following subsections.
2.2.2. Antioxidants and Alzheimer’s Disease Therapy
The vulnerability of CNS to oxidative damage is due to a number of
factors such as excessive oxygen uptake and high polyunsaturated lipid
content. One of the sources of oxidative stress in AD is the disturbance
in metal homeostasis (Sayre et al. 2001). Mitochondrial dysfunction is
another  source  of  ROS  generation  (Law et al. 2001). It has been
proposed that amyloid ? peptides in the presence of transition metal
ions produces ROS such as O2
?? and H2O2 (Varadarajan et al. 2000) and
microglial activation leads to a massive production of inflammatory
cytokines, ROS and RNS, thereby contributing to oxidative and
nitrosative damage (Scorer 2001).
Taking into account the various sources of oxidative stress, several
antioxidant activities can be suggested such as (i) free radical
scavenging e.g. vitamins  E  and  C,  selegiline  and  idebenone  (Castro et
al. 2002), (ii) mild to moderate metal chelation e.g. clioquinol (Bush
2003; Doraiswamy 2002; Rosenberg 2003), (iii) AGE-inhibition e.g.
Tenilsetam (Durany et al. 1999), (iv) inhibition of membrane lipid
peroxidation e.g. Lazabemide (Mason et al. 2000).
So far, no antioxidant drug has been approved for clinical use,
however, clinical studies of antioxidants continue in the hope of finding
a  suitable  treatment  in  the  near  future.  Examples  are Ginkgo biloba
extract, EGB761 and curcumin isolated from Curcuma longa which are
in phases III and II of clinical trials, respectively. Some plants and their
constituents e.g. sinapic acid, rosmarinic acid, salvianolic acids A and
B, honkiol and resveratrol which possess potent antioxidant activity
have shown biological and pharmacological activities which are
relevant to AD therapy (Dastmalchi et al. 2007a).
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2.2.3 Acetylcholinesterase Inhibition and Alzheimer’s Disease
Therapy
The selective degeneration of cholinergic neurons in AD results in
the loss of all known cholinergic markers, such as choline
acetyltransferase, ACh levels and AChE. ACh is associated with
cognition and it is the deficit of this neurotransmitter which contributes
to cognitive dysfunction. On the other hand, disruption of cholinergic
signalling may be contributing to the progression of AD pathology
(Lahiri et al. 2003). Therefore, restoration of the central cholinergic
function may significantly improve cognitive impairment and may
inhibit AD progression in patients.
Two types of cholinesterases, AChE and BuChE, are present in a
wide variety of tissues. AChE, which is the predominant cholinesterase
in the brain, hydrolyzes ACh to choline and acetate, thereby terminating
the effect of this neurotransmitter at cholinergic synapses (Small and
Mayeux 2005). AChE is, therefore, the target of cholinesterase
inhibitors and over the last two decades, AChE inhibition has become
the most effective clinical approach to treat the symptoms of AD.
However, AChE inhibitors so far have only been useful in the early
stages of AD and lose their effectiveness over time. Therefore, there is a
need to find more effective AChE inhibitors.
2.3 Medicinal Plants
Plants have been used since antiquity in traditional medicinal
systems for the treatment of memory dysfunction. Studies carried out on
some plant species have resulted in the identification of compounds
which are currently either in clinical use or are templates for further
drug discovery, e.g. galantamine, an alkaloid isolated from Galanthus
nivalis L. (Amaryllidaceae). Galantamine was approved by the FDA in
2004 for use as an AChE inhibitor in the treatment of AD (Jones et al.
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2006). It was the traditional use of G. nivalis L. in Bulgaria and Turkey
for neurological conditions that led to the development of this drug (Shu
1998). However, opinion about the traditional use of the plant is divided
(Heinrich 2004).
The importance of plant-derived compounds in drug discovery is
evident from a glance at the Prescription Drug Audit (Jones et al. 2006):
35 natural product-related drugs originally discovered from vascular
plants were among the 150 top selling drugs in 1993 (Jones et al. 2006).
The majority of plant-related drugs were discovered from ten plant
species, nine of which had been used traditionally for medicinal
properties that were related to the current therapeutic indication (Jones
et al. 2006). The strategy used for the discovery of new drugs based on
the screening of plants having medicinal uses relevant to the treatment
of a particular disease, is referred to as ethnopharmacological screening
(Samuelsson 2004). In a review carried out by Dastmalchi et al.
(2007a), this approach has been clearly shown to be useful in
identifying interesting templates for further drug developmental studies
against AD.
2.3.1. Dracocephalum moldavica L.
The plant D. moldavica L. commonly known as Moldavian balm is
a perennial herb belonging to the family Lamiaceae (Labiatae). This
plant is native to central Asia and is naturalized in eastern and central
Europe. In Iran, it is predominantly found in the north of the country,
especially in the Albourz Mountains, where it is known as “Badarshoo”.
It  is  frequently  consumed  as  a  food  additive  (e.g.  in  yogurt)  or  as  an
infusion for its organoleptic properties. As a herbal drug, it is used in
stomach and liver disorders, headache and congestion (Dastmalchi et al.
2007b, 2007c). Very few articles deal with the non-volatile chemistry
(Aynehchi et al. 1982; Kakasy et al. 2002) or antioxidant properties of
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Moldavian balm (Povilaityte and Venskutonis 2000; Povilaityte et al.
2001).
2.3.2. Melissa officinalis L.
The plant M. officinalis L.  belongs to the family Lamiaceae and
grows widely in central and southern Europe and in Asia Minor (Zargari
1990); however, it is cultivated throughout the world because of it’s
culinary properties. In Iran, this plant is known locally by the names
Badranjbooye, Varangboo and Faranjmoshk and is found in the north,
north west and western parts of the country (Anon 2002). It is used in
the  Iranian  traditional  system  of  medicine  for  the  treatment  of
headaches, flatulence, indigestion, colic, nausea, nervousness, anaemia,
vertigo, syncope, malaise, asthma, bronchitis, amenorrhea, cardiac
failure, arrhythmias, insomnia, epilepsy, depression, psychosis, hysteria,
ulcers and wounds (Zargari 1990; Anon 2002).
Although M. officinalis antioxidant studies have been carried out,
studies reporting upon the antioxidant activity of polar extracts of the
plant are limited (Ivanova et al. 2005; Ferreria et al. 2006;
Triantaphyllou et al. 2001; Venkutonis et al. 2005). As natural
antioxidants can exert their effect via a variety of different mechanisms,
it is important to assess fully their different modes of action and this is
not possible by conducting only a few assays (Part 1999). Therefore, as
a part of our on going antioxidant research on spices and herbs, an
aqueous ethanol extract of the plant was screened for its antioxidant
properties in a battery of in vitro assays. Furthermore, because it is
important to determine the constituents present in the extract, which
may be contributing to the activity, a compositional fingerprint analysis
was carried out using high performance liquid chromatography coupled
to photodiode array detector (HPLC-PDA).
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2.4 Methodologies for Antioxidant Screening
Antioxidants offer their protective action via a variety of different
mechanisms: (i) scavenging ROS/RNS (iii) metal chelation (iv)
induction of antioxidant enzymes and (v) inhibition of oxidative
enzymes.   The latter  two types of  mechanisms are not  covered as  they
are out of the scope of this current study.
 Antioxidants may respond in a different manner to different
radicals and oxidant sources. For example, phenolic compounds are
stronger scavengers of alkyl peroxyl radicals compared to that of
carotenes; however, the later are stronger scavengers of singlet oxygen
(Prior et al. 2005).
In vitro antioxidant methods can be divided into two general
categories: (i) competitive and (ii) non-competitive methods (Magalhães
et al.  2008). In the former type, an antioxidant sample has to protect a
substrate from ROS/RNS-mediated degradation. The antioxidant
activity is estimated based on the quantification of a substance that
facilitates the analytical measurement referred to as the probe
(Magalhães et al. 2008). Very often in competitive methods the probe is
the substrate or its oxidised form. However, the probe can also be a
compound that is added at the end of the assay to measure the quantity
of remaining substrate or the reactive species. Furthermore, activity of
the antioxidant sample depends on (Magalhães et al.  2008): (i) the rate
of reaction between the antioxidant sample and the ROS/RNS, (ii) the
rate of reaction between the substrate and the reactive species and (iii)
the ratio of the antioxidant sample and substrate concentrations.
The following are the requirement of this group of assays
(Magalhães et al. 2008): (i) the substrate/probe must react with the
ROS/RNS at low concentrations, (ii) the spectroscopic change between
the oxidized and native forms of the probe should be large enough to
maximize sensitivity, (iii) no radical chain reaction beyond
23
substrate/probe oxidation should take place and (iv) the antioxidant
should not react with the substrate.
Non-competitive methods are based on the assessment of the
scavenging ability of the antioxidant sample against ROS/RNS in the
absence of a substrate. In some of the assays the reactive species will
also probe the reaction.
2.4.1. Competitive Methods
Alkyl Peroxyl Free Radical Scavenging Assays
The harmful health effects of ROO? (Valko et al. 2007) and its role
in oxidative degradation of foods and cosmetics (Laguerre et al. 2007)
makes its scavenging significantly important. The result has been
development of analytical techniques for the assessment of ROO?
scavenging (Roginsky et al. 2005, Laguerre et al. 2007).
ROO? scavenging assays follow a competitive approach. The
methods measure the ability of the samples to scavenge ROO? by
hydrogen transfer reactions. The assay system consists of three
components: (i) thermolabile compound which yields carbon centered
free radicals that reacts rapidly with oxygen resulting in the formation
of ROO? free radicals, (ii) a substrate and (iii) the antioxidant sample.
The antioxidant and the substrate compete in order to react with the free
radicals (Magalhães et al. 2008).
The ORAC method, which was originally developed by Cao et al.
(1993), is an example of a ROO? scavenging assay. The principle behind
the assay is based on the reaction of ROO? with a fluorescent probe to
form a non-fluorescent product. The ROO? is generated by a free radical
source e.g. AAPH or AMVN. ?-Phycoerythrin from Prophyridium
cruentum, was initially used as the fluorescent substrate/probe which
after ROO? scavenging formed a non-fluorescent product (Cao et al.
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1993). The decay in the fluorescence was monitored throughout the
assay and its inhibition by the antioxidant sample was an indication of
ROO? scavenging effect of the sample (Prior et al. 2005). Batch to batch
variation, photobleaching and interaction with polyphenols by non-
specific protein binding were the drawbacks associated with the use of
?-phycoerythrin (Prior et al. 2005; Huang et al. 2005). To overcome
these limitations a synthetic compound, fluorescein, was used instead of
?-phycoerythrin (Ou et al. 2001).
One of the advantages of this assay is its ability to assess both
lipophilic and hydrophilic ROO? scavengers (Huang et al. 2002; Prior et
al. 2003). This can be done by altering the free radical source or by
changing the solvent (Prior et al. 2003; Naguib et al. 2003). Another
advantage of the method is that it can readily be automated for use in
high throughput screening procedures (Cao et al. 1995; Ou et al. 2001;
Huang et al. 2002).
The  reaction  in  the  ORAC  assay  is  temperature  sensitive,  thus
temperature variation across the wells in the microplate can result in
intra-assay variability (Prior et al. 2003). Fluorometers are not readily
available in analytical laboratories which, is another demerit of this
assay. Furthermore, oxidation of the substrate/probes in the assay does
not necessarily mimic oxidative stress in a biological medium (Frankel
et al. 2000).
The  TRAP  assay  was  introduced  by  Wayner et al. (1985) for
evaluating antioxidant activity of human plasma. The original method
used human plasma as the substrate and oxygen consumed in the
oxidation of plasma material was used as the probe molecule (Wayner
et al. 1985). The assay is based on the measurement of the lag time that
corresponds to the time between the beginning of the assay and the
beginning of the oxidation of  the plasma (Magalhães et al. 2008). Due
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to the shortcomings associated with detection of oxygen consumption,
modifications to the assay were made and substrates/probes such as ?-
phycoerythrin (DeLange et al. 1989) or ABTS (Bartosz et al. 1998) are
currently used. ROO? scavenging by these substances results in
spectroscopic changes which, are monitored optically or flurometrically.
The major drawback of the assay is the presence of too many
endpoints, thus making it difficult to compare data between laboratories
(Prior et al. 2005). The use of the lag phase in the measurement of
antioxidant activity is based on the assumption that all antioxidants
show a lag phase; however, not every antioxidant possesses an obvious
lag phase (Prior et al. 2005). Moreover, the activity after the lag phase
is totally ignored. The assay is time consuming and requires a high
degree expertise to perform (Prior et al.  2005).  The assay,  like that  of
the ORAC assay, does not simulate oxidative stress in a biological
medium (Frankel et al. 2000).
 Another ROO? scavenging assay is the ?-carotene-linoleic acid
bleaching inhibition assay. This method was initially developed by
Marco (1968) and later modified by Miller (1971). In the assay heat
induced oxidation of linoleic acid results in the formation of the free
radicals, which attack ?-carotene, leading to the loss of conjugation and
colour (Liyana-Pathirana et al. 2006).  Therefore, the inhibition of ?-
carotene bleaching is considered as a measure of antioxidant acitivy
(Liyana-Pathirana et al. 2006).
Cell membranes are rich in unsaturated lipids such as linoleic acid;
therefore, it has been argued that antioxidant samples capable of
preventing ?-carotene bleaching may have the ability to prevent in vivo
lipid peroxidation (Liyana-Pathirana et al. 2006).
The advantages associated with the assay are (Laguerre et al. 2007)
(i) sensitivity, (ii) relatively rapid reaction rate, (iii) simplicity, (iv)
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generation of visible results and (v) applicability to thin layer
chromatographic method.
One of the drawbacks associated with the assay is that the substrate
is oxidised under non-controlled conditions which makes it impossible
to obtain reproducible data (Roginsky et  al. 2005). Some researchers
have tried to overcome this by using free radical sources e.g. AAPH
instead of heat (Roginsky et al. 2005). Another drawback is interference
from compounds which absorb within the ?-carotene spectral window
can hamper measurements (Roginsky et  al.  2005).  It  is  not  easy  to
interpret the results because ?-carotene is itself an antioxidant
(Roginsky et al. 2005).
Superoxide Anion Free Radical Scavenging Assays
Most  of  the  analytical  methods  used  for  assessment  of  O2
?-
scavenging activity use the XOD/hypoxanthine system which at pH 7.4
generates the free radical (Lee et  al.  2002).  This  radical  can  also  be
generated by the non-enzymatic reaction of phenazine methosulphate in
the presence of NADH (Ewing and Janero 1995). In both these radical
generating systems, O2
?- reduction of NBT results in the formation of
formazan, which is spectrophotometrically monitored at 560 nm
(Aruoma et al. 1993; Ewing and Janero 1995). Antioxidants compete
with NBT, which is both a probe and the substrate, for O2
?- scavenging.
Another probe which has also been used is cytochrome c. Its constituent
iron(III) is reduced to iron(II) which can be monitored at 550 nm
(Aruoma et al. 1993). Cytochrome c reacts more rapidly with O2
?- than
NBT, therefore, it is more difficult for the antioxidant sample to inhibit
cytochrome c reduction. This is an example how the choice of probe can
influence evaluation of antioxidant activity (Magalhães et al. 2008).
All  variations  of  the  assay  suffer  from  the  drawback  that  the
samples may provide false positive results by interfering with O2
?-
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generation (Magalhães et al. 2008). An example is inhibition of the
enzyme xanthine oxidase by the sample suspected of antioxidant
activity.  The  samples  should  also  be  checked  if  they  reduce  NBT  or
cytochrome c (Magalhães et al. 2008).
Hydroxyl Free Radical Scavenging Assays
In  the  HO? scavenging assays the iron(III) ions and ascorbic acid
system results in the generation of a constant flux of HO? free radicals
which will attack 2-deoxy-D-ribose or brain phospholipids depending
on the probe used and form a series of degradation products (Halliwell
et al. 1987; Dastmalchi et al. 2007b). These products, which are known
as TBARS, react with TBA to give a pink chromogen (Halliwell et al.
1987). As a result of the competition between the antioxidant sample
and the substrate for the generated free radicals, the formation of
TBARS is inhibited. There are, however, cases in which compounds
investigated for their activity inhibit HO? generation by (i) scavenging
HO? precursors, e.g. H2O2, or (ii) chelating free iron(III) ions related to
HO? formation (Magalhães et al. 2008).
Therefore, in the non-site specific 2-deoxy-D-ribose  assay,  the
performance of the antioxidant samples is assessed in the presence of
EDTA. This allows the evaluation of a potential antioxidant activity
unrelated to transition metal ion chelation (Magalhães et al. 2008). In
the presence of EDTA, iron(III) ions are no longer bound to the 2-
deoxy-D-ribose  and  therefore  HO? damage is non-site specific and
inhibition  of  TBARS  is  due  to  direct  HO? scavenging action
(Dastmalchi et al. 2007b; Magalhães et al. 2008).
Hydrogen Peroxide Scavenging Assays
One of the most common methods in assessing H2O2 scavenging is
based on its intrinsic absorption within the UV region which was first
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developed by Beers et al. (1952). As the concentration of H2O2
decreases the absorbance at 230 nm will also decrease. Sometimes the
samples also absorb within this region, thus there is a need for blank
measurements. However there are still demerits which affect accuracy
and precision of the assay. In the case of strong background absorption
it will be very difficult to investigate any change in the absorption. The
other shortcoming is that absorption of the sample may change after the
reaction, thus making the blank measurements irrelevant (Magalhães et
al. 2008).
Fluorometric methods have also been used for measuring H2O2
scavenging activity. An example is the one employing homovanillic
acid, which upon oxidation with H2O2 is converted to its fluorescent
biphenyl dimmer. H2O2 scavenging activity results in fluorescence
decay (Pazdzioch-Czochra et al. 2002). Horseradish peroxidase has
been used as a source of H2O2 generation in the assay and its inhibition
or interference with its activity results in erroneous results (Magalhães
et al. 2008).
Singlet Oxygen Scavenging Assays
Singlet oxygen is molecular oxygen in an excited state without
unpaired electrons. Therefore, despite being a powerful oxidising agent
it is not considered as a free radical (Halliwell 2006). 1O2 emits
characteristic light during its decay from a high energy state to a lower
one, known as phosphorance at 1270 nm. 1O2 scavenging of some of the
compounds has been assessed using this property (Wilkinson et al.
1995). However, usually the intensity of phosphorance is insufficient to
provide reproducible quantitative information (Magalhães et al. 2008).
A more sensitive approach using the fluorescence probe tetra-tert-
butylphthalocyanine copper was developed (Fu et  al. 1997). This
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method has been used for the estimation of rate constants of many 1O2
scavengers.
Nitric Oxide Free Radical Scavenging Assays
NO? plays an important role in the regulation of a variety of
physiological and pathological processes e.g. AD (Valko et al. 2007;
Varadarajan et al. 2000; Law et al. 2001; Moncada et al. 1991; Tamir
and Tannenbaum 1996). Assessment of NO? scavenging activity can be
done in a number of ways. One of the approaches is based on the use of
amperometric measurement of NO? scavenging of sulphur containing
compounds using NO? sensors (Vriesman et al. 1997). The radical is
added to the buffered solution of the scavenger and its concentration is
monitored during the assay. There is a linear relationship between
natural logarithm of the NO? levels and time. Another approach for the
determination of NO? scavenging uses the Griess reaction. In these types
of  assays,  the  remaining  NO? is converted into an azo-derivatives of
nitrite, which are measured at 540 nm (Marcocci et al. 1994;
Dastmalchi et al. 2008).
Peroxynitrate Free Radical Scavenging Assays
One of the assays used in assessing ONOO?- scavenging is based on
tyrosine nitration. Tyrosine upon reaction with ONOO?- forms 3-
nitrotyrosine which is measured using HPLC-PDA (Magalhães et al.
2008; Pollards et al. 2006). In the presence of an ONOO?- scavenger the
formation of 3-nitrotyrosine is inhibited which is estimated in terms of
percentage of inhibition (Pollards et al. 2006).
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2.4.2. Non-Competitive Methods
2,2?-Azinobis(3-ethylbenzothiazoline-6-sulphonate) Cation Free Radical
Scavenging Assay
This assay is also referred to as the TEAC assay. This assay
involves the generation of ABTS?+, which has absorption maxima at
414, 645, 734 and 815 nm (Re et al. 1999). Among them, 734 nm is the
most commonly used wavelength for monitoring ABTS?+ scavenging
spectrophotometrically. Reduction of the free radical cation results in
discoloration which is a measure of the antioxidant activity (Re et al.
1999). There have been a number of modifications done to the assay. In
the original method metmyoglobin and H2O2 were used to generate
ferrylmyoglobin, which then reacted with ABTS to form ABTS?+
(Miller and Rice-Evans  1993). The antioxidant sample was added in
the reaction medium before ABTS?+ was formed. This presented a
problem in that the antioxidant reacted with the oxidizing reagent before
the complete formation of ABTS?+ had occurred which led to an
overestimation of antioxidant activity (Strube et  al. 1997). In later
methods the antioxidant sample to be tested was added after the
generation of ABTS?+ (Re et al. 1999). An example is the assay
employed in the current  study.  After  the free radicals  are  generated by
the action of potassium peroxosulphate on ABTS, the antioxidant
sample is added to the reaction mixture. The scavenging ability of the
sample is estimated in terms of percentage inhibition of  ABTS?+
absorbance at 734 nm relative to the reactivity of Trolox as reference
standard under the same condition (Dastmalchi et al. 2007b,c;
Dastmalchi et al. 2008).
The simplicity of the assay accounts for its wide application in
many laboratories as a routine screening method. In addition to this
merit  the  assay  can  be  used  over  a  wide  pH  range  (Lemanska et al.
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2001) and due to ABTS?+ solubility in aqueous and organic phase both
hydrophilic and hydrophobic samples can be evaluated for their
activities (Re et al.  1999). The assay has the potential to be automated
and adapted to microplates (Erel 2004).
The ABTS?+ is  not  a  physiological  radical,  thus  the  assay  is  not
representative of a biological system. Another limitation of the assay is
that any compounds having lower redox potential than ABTS?+ is
capable of reducing it, thus most phenolics can reduce ABTS?+.
Furthermore, as TEAC values are determined at a specific time interval,
the  results  may  not  be  reflective  of  the  true  antioxidadnt  activity  of  a
sample as antioxidants are capable of both fast and slow reactions (Prior
et al. 2005).
1,1?-Diphenyl-2-picrylhydrazyl Free Radical Scavenging Assay
The DPPH? is a stable nitrogen-centred free radical with a deep
purple colour, which unlike ABTS?+ it is commercially available and
does not have to be produced before the assay is carried out. Reduction
of DPPH? by the antioxidant sample results in a change of colour from
purple to pale yellow (Magalhães et al. 2008; Prior et al. 2005). The
scavenging activity is usually determined in organic media (normally in
MeOH) by measuring the change in the absorbance at 515-518 nm until
the absorbance remains constant (Magalhães et al. 2008). The
discolouration method was first developed by Brand-Williams et al.
(1995). Contrary to the initial view the reaction mechanism is based on
electron transfer reaction and hydrogen atom transfer is a marginal
pathway (Magalhães et al. 2008). As it has been demonstrated by Foti et
al. (2004), DPPH? scavenging activity is strongly influenced by the
solvent used and the pH of the reaction mixture. In the version of the
assay used in the current study pH is maintained at pH 7.4 by using
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Tris-HCl buffer. The results are reported in terms of the concentration
of sample required to decrease the initial concentration of DPPH? by 50
% (IC50 ) (Dastmalchi et al. 2007b,c; Dastmalchi et al. 2008).
The merits  of  the assay can be summed up as  its  simplicity,  speed
and the requirement of only readily available instruments, e.g. a UV-Vis
spectrophotometer (Prior et al. 2005). However, when a test sample,
e.g. fucoxanthin, absorbs light within the same region as DPPH?,
measurement will be difficult to perform (Noruma et al. 1997). Another
problem is steric accessibility as a result of which small molecules that
have easier access to DPPH? will be considered as more active relative
to large antioxidant compounds (Prior et al. 2005). DPPH? like ABTS?+
is not a physiological radical and its bears no similarity with ROS
present in biological systems (Prior et al. 2005) .
Folin-Ciocalteu Reagent Assay
The original Folin-Ciocalteu method was developed for tyrosine
analysis (Folin 1927), which was later on improved by Singleton et al.
(1999). The improved method has been used for estimation of total
phenols. The reagent used is a molybdotungastophosphoric
heteropolyanion reagent. The chem-istry behind the assay relies on the
electron transfer from phenolic compounds to molybdenum, forming
blue complexes that can be detected at 750-760 nm (Singleton et al.
1999).
                         Mo(VI) + e- ? Mo(V)
It is believed that molybdenum can be reduced more easily once it
is in a complex form. Blue complexes are formed independently of the
structure of the phenolic groups. This rules out the possibility of
coordination complex formation during the course of the assay
(Singleton et al. 1999). Gallic acid is generally used as the reference
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standard and the phenolic content of the sample is estimated in terms of
gallic acid equivalence.
The Folin-Ciocalteu method is simple and can be used in
standardising many botanical samples. Excellent correlation between
the assay and other electron transfer methods e.g. DPPH? has been
established (Roginsky et al. 2005). The assay suffers from certain
drawbacks. A number of interfering substances such as sugars, aromatic
amines,  sulphur  dioxide,  ascorbic  acid,  Cu(II)  and  Fe(III)  react  with
Folin-Ciocalteu reagent to give false positive results (Prior et al. 2005;
Singleton et al. 1999).
Iron(III) Reduction Assay
The method is based on the reduction of the substrate Fe3+ and
Fe(CN)6
3- ions and the subsequent formation of Fe2+ and  Fe(CN)6
4-.
These species combine to form a Prussian blue complex Fe4[Fe(CN)6]3
which is the chromogen (Van-Middlesworth and Cannell 1998). The
reducing power of the antioxidant sample is assessed by the change in
the absorbance due to the formation of the complex (Oyaizu 1986).
Ascorbic acid is used as the standard reference and the activities of the
samples are presented in terms of AscAE (Dastmalchi et al. 2007b).
2.4.3. Overall Prospective
A large number of assays with different reaction mechanisms,
substrates, probes and free radical sources have been discussed. Given
the fact that antioxidants act via a variety of different mechanisms it is
beneficial to screen them using a battery of different assays in order to
characterise them fully.
As our understanding of oxidative stress increases, so does our need
for more in vitro analytical methods. In designing novel methods,
substrates and probes should be chosen that are of biological relevance
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and as far as possible related to the disease under investigation. The
reaction conditions e.g. temperature, pH, concentration and reaction
time should reflect the oxidative stress conditions in vivo. Other
important criteria while designing assays are simplicity, available
instrumentation, defined endpoint, adaptability to hydrophilic and
hydrophobic conditions and adaptability to high throughput analysis.
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3. AIMS OF THE STUDY
The current study was aimed at screening Dracocephalum
moldavica and Melissa officinalis for bioactivities relevant to AD
therapy. In order to achieve the stated aim, specific objectives were
defined as follows.
Objective:
1. Literature Review: Investigating the Potential of Plants, including
Melissa officinalis L. in AD (Study I)
2. Antioxidant Screening of HWE of Dracocephalum moldavica L.
(Study II)
3. Antioxidant Screening of SEs of Dracocephalum moldavica  L.
(Study III)
4. AChE Inhibitory Screening of Melissa officinalis (Study IV)
5. AChE Inhibitory Guided Fractionation of Melissa officinalis
(Study V)
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4. EXPERIMENTAL
4.1. Chemicals and Reagents
Standard compounds, reagents and solvents used in the current
study along with their source of purchase are presented in Table 1.
Water (HPLC grade) was prepared using a Millipore Plus system.
4.2. Botanical Material
Aerial material of D. moldavica was purchased form a herbal
products retailer in Tehran, Iran. Air-dried leaves of M. officinalis
(Specimen No. GeLM175) were obtained from the Institute of
Medicinal Plants, Iranian Academic Center for Education, Culture and
Research (Halejrad, Iran). The taxonomic identity of the plants was
confirmed by a botanist from the department of Cultivation and
Development of the Institute of Medicinal Plants (Tehran, Iran).
4.3. Extraction Techniques
4.3.1. Hydrodistillation
This method was used for the preparation of the plant extract used
in study II. Air-dried plant material was placed in a 500 mL round
bottom flask and 250 mL water was added. The flask was connected to
Eur. Ph. hydrodistillation apparatus and the water was boiled for 2 h.
The volatile oil extracted was discarded and the water extract was
separated from the plant material by filtration. The process was repeated
with fresh extractant a further two times. The extracts were pooled,
filtered, concentrated in vacuo (45°C), lyophilised and stored at 4 °C
until required for analysis. This extract is referred to throughout the text
as the HWE.
4.3.2. Soxhlet Extraction
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This method was used for the preparation of the plant extracts used
in study III.  Air-dried  plant  material  was  packed  into  a  paper  thimble
and inserted into a Soxhlet apparatus. The plant material was
exhaustively extracted in a sequential manner with 250 mL PE, CH2Cl2,
ACN, EtOAc, MeOH, n-BuOH  and  H2O. The organic extracts were
dried over anhyd. magnesium sulphate and their solvents were removed
in vacuo (40°C). The water extract was concentrated in vacuo (40 °C)
and lyophilised. All extracts were stored at 4°C until required for
analysis.
4.3.3. Medium Pressure Solid Liquid Extraction
This method was used for the preparation of the plant extract used
in studies IV and V. The air-dried leaves of the plant were extracted
with 45 % (v/v) aq. ethanol using medium pressure solid liquid
extraction. The column used was manufactured by Büch (Büch
Laboratorium Tecknic Ag, Switzerland) and the ratio of material to the
extractant was 1:5.4 (w/v). The incubation period and the time between
the runs was 3 h and each run took 45 min at a flow rate of 3 mL/min.
The plant material was extracted in two batches of 200 g and 250 g and
the number of runs were 8 and 10, respectively. Finally, the extracts
from all the runs were pooled and concentrated in vacuo at  45  °C,
lyophilized and stored at 4 °C until required for analysis.
4.4. Chromatographic Techniques
4.4.1 High Performance Liquid Chromatography-Photodiode Array
Analysis
Method A
The chromatographic method used in study II was as follows. The
HPLC system (Shimadzu LC 10 Avp) consisted of an in-line degasser,
pump and controller coupled to a SPD-M10 Avp PDA detector
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equipped with an automatic sampler interfaced to PC running Class VP
chromatography manager software (Shimadzu). Separations were
performed on a 250 x 4.6 mm i.d., 5 µm particle size, reverse-phase
Discovery-C18 analytical column (Supelco) operating at room
temperature. Detection was carried out with a sensitivity of 0.1 auf
between the wavelengths of 200 to 550 nm. Elution was done by using a
binary non-linear gradient of 5% aq. formic acid (solvent A) and ACN
(solvent B). The changes in the mobile phase composition during each
chromatographic run can be seen in Table 2.
All extracts and standards were dissolved in 70% aq. ACN at a
concentration of 1 mg/mL and 10 mg/mL, respectively. The
concentration used for the calibration of reference compounds was 0.00-
0.10 mg/mL. All standard and sample solutions were injected in
quadruplicate.
Method B
The chromatographic method used in study III was as follows. The
HPLC system (Waters 600E) consisted of an in-line degasser, pump and
controller coupled to a 991 photodiode array detector equipped with a
717 automatic sampler (20 µL injection volume) interfaced to a PC
running PDA 991 software (Waters Corp., Milford, MA). Separations
were performed on a 250 × 4.6 mm i.d., 5 µm reverse-phase Hypersil
BDS-C18 analytical column (Agilent Technologies). Detection was
carried out with a sensitivity of 0.1 auf between the wavelengths of 200
and 550 nm. Elution was done by using a ternary nonlinear gradient of
the solvent mixture MeOH/H2O/CH3COOH (10:88:2, v/v/v) (solvent
A), MeOH/H2O/CH3COOH (90:8:2, v/v/v) (solvent B) and MeOH
(solvent C).
Stock solutions of the extract and standards were prepared in 70%
aq. MeOH to final concentrations of 1 and 10 mg/mL, respectively. The
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concentration range used for calibration of the standard compounds was
0.01-0.10 mg/mL. All standard and sample solutions were injected in
duplicate.
Method C
The chromatographic method used in study IV was as follows. The
instrumentation was the same as described in method B. Detection was
carried out with a sensitivity of 0.1 aufs between the wavelengths of 200
and 550 nm. Elution was done by using a binary non-linear gradient of
the solvent mixture 0.2 % aq. TFA (solvent A) and MeOH (solvent B).
Composition of the mobile phase changed according to Table 4.
Components were identified by comparison of their retention times to
those of authentic standards under identical analysis conditions and by
comparison of their UV spectra with an in-house PDA-library.
Stock solutions of the extract and standards were prepared in 45%
aq. ethanol and 70% aq. methanol to final concentrations of 1 and 10
mg/mL, respectively. The concentration range used for calibration of
the standard compounds was 0.001-0.10 mg/mL. The standards and
samples were injected in duplicate.
4.4.2. Fractionation
Chromatographic based fractionation was performed in study V
using a HPLC system (Waters 2545) consisting of a binary gradient
module  and  active  flow  splitter  coupled  to  a  PDA  detector  (Waters
2996), a mass spectrometer (Waters), a make up  pump (Waters 515)
and a sample manager (Waters 2767) interfaced to a PC running
MassLynx 4.1 software (Waters). Separations were performed using
Supelco C18 discovery column (25 cm x 10 mm, 5 µm) along with a
Supel guard discovery C18 precolumn (1 cm x 10 mm, 5 µm) and a
binary non-linear  gradient  of  0.02%  aq.  TFA (Solvent  A) and MeOH
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(Solvent B). The composition of the mobile phase was changed as
described in Table 5.  The injection volume of the extract was 3 mL at a
concentration of 5 mg/mL. UV monitoring was carried out at 280 nm
and the fractionation was time based as shown in Table 6.
4.4.3. Liquid Chromatography-Diode Array Detector-Electrospray
Ionisation-Mass Spectrometry
The chromatographic method used in study V was as follows. The
HPLC system (Agilent 1100 series) consisted of an automatic sampler,
binary pump, an online degasser, heated column compartment, coupled
to a DAD detector (Agilent 1100 series) interfaced to a PC running HP
ChemStation Plus A.07.01. software (Agilent  Technologies).
Separation was performed using Luna C18(2) (150 mm x 1 mm, 5 µm,
Phenomenex Ltd.). Elution was carried out using binary non-linear
gradient  of  0.02%   aq.  TFA  (Solvent  A)  and  0.02%  TFA  in  MeOH
(Solvent B). The mobile phase composition changed according to Table
7.  The column was maintained at a constant temperature of 30 °C. The
injection volume of the fraction was 3 µL. UV monitoring was done at
280 nm and 360 nm channels.
Mass spectrometric analysis was carried out using an Esquire-LC
quadruple ion trap mass spectrometer equipped with an electrospray
interface (Bruker Daltonics, Berman, Germany) controlled using
Esquire-LC NT 3.1 (Bruker Daltonics) software. Electrospray ionization
was performed in both negative and positive modes. When using
negative mode scan range of 100-700 m/z, capillary exit voltage of 85
volts and Trap drive value of 36 were used. During positive mode
ionization a scan range of 100-700 m/z, capillary exit voltage of 35 and
a trap drive value of 43 was used. Helium was used as the collision gas.
41
4.5. Antioxidant Methods
4.5.1. Iron(III) Reduction
The ability of the plant extracts to reduce iron(III) to iron(II) ions
was assessed in studies II, III and IV by the method described by
Oyaizu (1986). Briefly, 1 mL sample was mixed with 2.5 mL phosphate
buffer (0.2 M, pH 6.6) and 2.5 mL 1% (w/v) potassium
hexacyanoferrate solution. After 30 min at 50 ?C, 2.5 mL 10% (w/v)
TCA was added and the mixture was centrifuged for 10 min (2000
rpm). Finally, a 2.5 mL aliquot was mixed with 2.5 mL ultra-pure water
and 0.5 mL 0.1% (w/v) iron(III) chloride and the absorbance was
recorded at 700 nm. Values are presented as ascorbic acid equivalents
(AscAE, µmol ascorbic acid/g sample).
4.5.2. Iron(II) Chelation
The ability of the plant extracts to chelate iron(II) ions was assessed
in studies II and IV, by the method described by Carter (1971). Briefly,
to a 200 µL of dissolved extract was added 100 µL (2.0 mM) iron(II)
chloride tetrahydrate and 900 µL methanol. After a 5 min incubation,
the reaction was initiated by the addition of 400 µL (5.0 mM)
ferrozine. After a further 10 min incubation period, the absorbance at
562 nm was recorded. The percentage chelating activity was calculated
using Eq. 1 and the concen-tration at which the extract exerts 50% of its
effect (EC50) was estimated by a linear regression algorithm.
  Percentage Chelation =
? ?
100
Abs
Abs-Abs
control
samplecontrol
x??
?
??
?
  (Eq. 1)
4.5.3. 1,1?-Diphenyl-2-picrylhydrazyl Free Radical Scavenging
The ability of the plant extracts to scavenge DPPH? free radicals
was assessed in studies II, III and IV by the method described by
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Gyamfi et al. (1999). Briefly, a 50 µL aliquot of dissolved extract was
mixed with 450 µL Tris–HCl buffer (50 mM, pH 7.4) and 1.0 mL (0.1
mM) DPPH? dissolved in methanol. After a 30 min reaction period, the
resultant absorbance was recorded at 517 nm. The percentage inhibition
was calculated using Eq. 2 and the concentration of the extract at which
it exhibits 50% inhibition (IC50) was estimated using a non-linear
regression algorithm.
Percentage Inhibition =
? ?
100x
Abs
Abs-Abs
control
samplecontrol
??
?
??
?
  (Eq. 2)
4.5.4. 2,2?-Azinobis(3-ethylbenzothiazoline-6-sulphonate) Cation Free
Radical Scavenging
The ability of the plant extracts to scavenge ABTS?+ free radical
scavenging was assessed in studies II, III, IV by the method described
by Re et al. (1999). Briefly, the ABTS?+ radical was generated by
reacting a 7 mM ABTS aqueous solution with potassium
peroxosulphate (2.45 mM, final concentration) in the dark for 12–16 h,
at ambient temperature, and adjusting the Abs734 nm to 0.700 (?
0.020) with ethanol. The samples were diluted, such that, a 15 µL
sample when added to 1.485 mL ABTS?+ resulted in a 20–
80% inhibition of the blank absorbance. After 1.485 mL
ABTS?+ solution was added to 15 µL sample, the absorbance at 734 nm
was recorded 1 min after initial mixing and subsequently at 5 minutes
intervals (40 min, in toto). The results are expressed as the Trolox
equivalent antioxidant capacity (TEAC, mM Trolox) at different time
intervals.
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4.5.5. Peroxyl Free Radical Scavenging (?-Carotene-linoleic Acid
Bleaching Inhibition)
The ability of the plant extracts to inhibit the bleaching of the ?-
carotene-linoleic acid emulsion was assessed in studies III and IV using
a modification of the method described by Koleva et al. (2002). Briefly,
0.2 mg ?-carotene dissolved in 1 mL chloroform, 20 mg of linoleic acid
and 200 mg of Tween 20 were transferred into a round-bottom flask.
Once the chloroform had been removed under nitrogen, 50 mL distilled
H2O was added and the resulting mixture was vigorously stirred for 30
minutes. Thereafter, 5 mL aliquots of this emulsion were transferred to
tubes containing either 200 µL of dissolved extract (1 mg/mL) or 200
µL of positive controls (1 mg/mL). After mixing, the absorbance (Abs0)
at 470 nm was recorded. The remaining samples were placed in a water
bath at 50 ?C for a period of 2 h. Thereafter, the absorbance of each
sample was remeasured at 470 nm (Abs120).  The  data  (n =  2)  are
presented as antioxidant activity % (AA%) values, calculated using Eq.
3.
? ?
100x
)Abs-(Abs
Abs-Abs
-1%AA
control120control0
sample120sample0
?
?
?
?
?
?? (Eq. 3)
4.5.6. Superoxide Anion Free Radical Scavenging
The ability of the plant extracts to scavenge superoxide anion
radicals was assessed in studies II and IV by the method described by
Lee et al. (2002). Briefly a 100 µL aliquot of dissolved sample was
taken, to which it was added: 100 µL (30 mM) Na2EDTA, 100 µL (3
mM) hypoxanthine in 50 mM NaOH and 200 µL (1.42 mM) NBT in
NaH2PO4-NaOH buffer (50 mM, pH 7.4). After a 3 min incubation
period at room temperature, 100 µL (0.5 U/mL) XOD in the NaH2PO4-
NaOH buffer was added followed 2.4 mL NaH2PO4-NaOH buffer. The
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resulting solution was incubated at room temperature for 20 min and the
absorbance at 560 nm was measured.  The absorbance was also
measured at 293 nm to detect if the extract inhibited uric acid
generation. Once it was confirmed that uric acid formation is not
inhibited, then the percentage inhibition at 560 nm was calculated using
Eq. 2 and IC50 values were estimated using a non-linear regression
algorithm.
4.5.7. Hydroxyl Free Radical Scavenging
Ascorbate-Iron(III)/EDTA-H2O2-Catalysed2-Deoxy-D-ribose Degradation
The ability of the plant extract to inhibit hydroxyl radical-mediated
2-deoxy-D-ribose degradation was assessed in study II by the method
described by Halliwell et al. (1987). The reaction mixture contained 500
µL of extract dissolved in 50 mM KH2PO4-KOH buffer (pH 7.4), 100
µL of 28 mM 2-deoxy-D-ribose in KH2PO4-KOH buffer, 200 µL of a
premixed 100 µM FeCl3, and 104 mM Na2EDTA (1:1 v/v) solution, 100
µL of 1.0 mM hydrogen peroxide and 100 µL of 1.0 mM aq. ascorbic
acid. Tubes were vortexed and incubated at 37 °C for 60 min.
Thereafter, 50 µL of 2% (w/v) BHT was added to each tube followed by
1  mL  of  2.8%  (w/v)  TCA  and  1  mL  of  1%  (w/v)  TBA  (in  0.05  M
NaOH). The samples were vortexed and heated in a water bath at 100
°C for 20 min. The reaction was stopped by placing the test tubes in an
ice-H2O bath for 5 min. To each tube was added 2 mL of n-butanol and
the mixture was vigorously vortexed. After centrifugation, the extent of
oxidation was estimated from the absorbance of the organic layer at 532
nm. The percentage inhibition was calculated using equation 2 and the
IC50 values were estimated using a non-linear regression algorithm.
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Ascorbate-Iron(III)-Catalysed Phospholipid Degradation
The ability of the plant extract to inhibit hydroxyl radical-mediated
phospholipid degradation at physiological pH was assessed in study II
by the method described by Aruoma et al. (1997). Bovine brain extract
was mixed with 10 mM PBS (pH 7.4) and sonicated in an ice bath until
an opalescent suspension was obtained containing 5 mg/mL
phospholipid liposomes. The liposomes (0.2 mL) were combined with
0.5 mL of PBS buffer, 0.1 mL of 1 mM FeC13, and 0.1 mL of sample
dissolved in an appropriate solvent. The peroxidation was initiated by
adding 0.1 mL of 1 mM aq. ascorbic acid. The mixture was incubated at
37 ?C  for  60  min.  After  incubation,  50  µL  of  2%  (w/v)  BHT  (in
ethanol) was added to each tube, followed by 1 mL of 2.8% (w/v) TCA
and 1 mL of 1% (w/v) TBA in 0.05 M NaOH. The solutions were
heated in a water bath at 100 ?C for 20 min. The resulting (TBA)2-MDA
chromogen was extracted into 2 mL of n-butanol and the extent of
peroxidation was determined in the organic layer at 532 nm. The
percentage inhibition was calculated using equation 1 and IC50 values
were estimated using a non-linear regression algorithm.
4.5.8. Nitric Oxide Free Radical Scavenging
The ability of the plant extract to scavenge nitric oxide free radicals
was assessed in study IV using a modification of the method described
by Marcocci et al.  (1994).  Briefly,  a  0.5  mL  aliquot  of  extract  (1
mg/mL) or positive control (1 mg/mL) dissolved in KH2PO4-KOH (50
mM, pH 7.4) was mixed with 0.5 mL of (10 mM) sodium nitroprusside
solution. The mixture was incubated at 37 ?C for 2.5 hours under
normal light conditions. After incubation the sample was placed in dark
for 20 minutes. Thereafter, 1 mL of Griess reagent (0.1% N-(1-
naphtyl)ethylenediamine and 1% (w/v) sulfanilamide dissolved in 2%
(w/v) aqueous H3PO4) was added and the absorbance was taken after 40
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minutes at 546 nm. The percentage inhibition was calculated using Eq.
2.
4.6. Miscellaneous Methods
4.6.1. Acetylcholinesterase Inhibitory Screening
The ability of the plant extract to inhibit AChE was assessed in
study V using a 96 well plate format by the method described by
Oinonen et al. (2006). Twenty five microlitres of plant extract dissolved
in 50 mM Tris buffer (pH 8) was added to the wells in a 96 well plate,
followed by 25 µL of 15 mM ATCI in H2O, 125 µL of 3 mM DTNB in
50 mM Tris buffer containing 0.1 M NaCl and 0.02 M MgCl2.6H2O (pH
8) and 50 µL of 50 mM Tris buffer containing 0.1% (w/v) BSA. The
absorbance at 405 nm was measured ten times during ten minutes
(spontaneous hydrolysis) using a Victor2 multilable counter (Perkin
Elmer Life and Analytical Sciences/Wallac Oy, Turku, Finland). Then,
25 µL of 0.226 U/mL AChE in 50 mM Tris buffer containing 0.1%
(w/v) BSA was added to start the reaction and the measurement was
repeated. The absorbance readings were corrected by subtracting from
them the spontaneous hydrolysis values. AChE inhibitory effect of the
sample was estimated in terms of percentage inhibition, which is
percentage change in absorbance compared to the control using Eq. 4.
PHY was used as the reference standard. Concentration-response curves
for the sample and PHY were plotted using percentage inhibition values
vs. concentration. The potency of the extract was calculated from the
standard response curve of PHY using linear regression analysis. The
potency values were expressed as PHY equivalents  (PhE, µg PHY/mg
(dry wt.) extract).
47
Percentage Inhibition =
? ?
100
AbsAbs
Abs-Abs
1
samplet-sample1
controltcontrol1
x??
?
??
? ?  (Eq. 4)
Where control1Abs   is the absorbance of the control sample at 1 minute,
controltAbs  is  the  absorbance  of  the  control  sample  at  t  minutes,
sample1Abs is the absorbance of control at 1 minute and sampletAbs      is
the absorbance of control at t minutes.
4.6.2. Statistical Analysis
Data were presented as mean values ? 95% confidence interval.
Analysis of variance was performed using ANOVA procedures.
Significant differences between means were deter-mined by Tukey’s
pairwise comparison test at a level of P < 0.05. Microsoft Office Excel
2003, Sigmaplot 2001 and Minitab 10.5 software were used for the
statistical analysis.
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5. RESULTS AND DISCUSSION
5.1. Dracocephalum moldavica
5.1.1. Yield and Phenolic Composition
During hydrodistillation of D. moldavica, volatile aroma
constituents were removed from the plant material and polar
constituents remained in the hot water extract (HWE). The yield of the
HWE (496 mg/g) from study II was higher than SE yields obtained in
study III.  The yields of SEs range from 3.7 mg/g (EtOAc and n-BuOH
extracts) to 109.2 mg/g (MeOH extract), and increasing in the order
EtOAc and n-BuOH (no significant difference, P >  0.05)  <  ACN  <
CH2Cl2 < PE < H2O < MeOH.
The total phenolic content of the extracts, as estimated by the Folin-
Ciocalteu method, ranged from non-detected amounts (PE extract) to
488.4 ? 1.8 mg gallic acid/g (MeOH extract). The total phenol content
of the extracts increased in the order PE < CH2Cl2 < ACN < EtOAc <
H2O  < n-BuOH  <  HWE  <  MeOH.  It  can  be  clearly  seen  that  the
extraction yields did not follow the order of total phenolic contents.
This is due to the fact that plant extracts, especially of low polarity e.g.
PE and CH2Cl2, extracts containing phytochemicals other than phenolics
such as fatty acids and waxes.
Dracocephalum species are known to contain a range of secondary
metabolites, such as terpenoids, flavonoids, both glycosides and
aglycones, and hydroxybenzoic and hydroxycinnamic acids (Gohari et
al., 2003; Saeidnia et al. 2005). In study II using HPLC-PDA method
A, phenolic compounds in the HWE were classified and quantified as
hydroxycinnamic acids and flavonoids, respectively. The components
identified, in their increasing order of abundance, were luteolin <
luteolin-7-O-glucoside  <  apigenin  <  ferulic  acid  <  rosmarinic  acid  <
caffeic acid. This is in agreement with previous studies whereby caffeic
49
acid derivatives, i.e. caffeic and rosmarinic acids, and flavonoids were
identified as the principal components of D. moldavica (Gu et al. 2004)
and other Dracocephalum species (Gohari et al., 2003).
The total phenolic content of the extract (145.59 ? 0.62 mg/g)
determined in study II by  HPLC-PDA  method  A  was  similar  to  the
value determined by Folin-Ciocalteu method (145.3? 18.9 mg/g).
In study III using HPLC-PDA method B, phenolic compounds in
the SEs were classified and quantified as hydroxybenzoates,
hydroxycinnamates and flavonoids. The components identified, in their
increasing order of abundance, were apigenin < p-coumaric acid <
quercetin and caffeic acid < ferulic acid < apigenin-7-O-glucoside <
chlorogenic acid < rosmarinic acid. This is in general agreement with
previously published qualitative-quantitative analyses of Lamiaceae
species (Shan et al.  2005; Triantaphyllou et al. 2001). Rosmarinic acid
was  present  in  all  the  extracts  with  the  exception  of  PE  and  CH2Cl2
extracts, however, the n-BuOH and MeOH extract had the highest
content. The content of rosmarinic acid in the alcoholic extracts (n-
BuOH and MeOH) was even higher compared to that found in the
HWE. This can be explained in terms of high polarity of the solvents
and their ability to penetrate cell membranes and extract intracellular
material.
The total phenolic content of the extracts determined in study III by
HPLC-PDA method B increased in the order PE < CH2Cl2 < EtOAc <
ACN < H2O < MeOH < n-BuOH was different from the trend observed
in case of Folin-Ciocalteu reagent method. The total sum of phenolic
contents of the extracts (476.59 ? 25.22 mg/g) determined by HPLC-
PDA method B was also different from the value determined by Folin-
Ciocalteu method (848.5 ? 3.12 mg/g). These results show the
limitation of the Folin-Ciocalteu method. As previously mentioned,
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interfering substances such as sugars react with Folin-Ciocalteu reagent
to produce false positive results. It can also be seen from the results, that
the solvent n-BuOH is even more effective than MeOH for the
extraction of phenolic compounds when a Soxhlet apparatus is used.
This may be due to absence of extensive intermolecular hydrogen
bonding, thus it is easier for phenolic compounds to dissolve in n-
BuOH.
Based  on  the  results  presented,  a  scheme  can  be  designed  for  the
optimum extraction of phenolic compounds from D. moldavica aerial
material using a Soxhlet apparatus. The plant material can be defatted
by  initial  extraction  with  PE  followed  by   CH2Cl2, then the phenolic
components can be extracted with n-BuOH.
5.1.2. Antioxidant Properties
Iron(III) to iron(II) reduction
Study II
The HWE of D. moldavica demonstrated the ability to reduce
iron(III) to iron(II) ions. The reducing power of the extract and positive
controls increased in the order  HWE < Pycnogenol (a standardized
extract of Pinus pinaster Aiton  )  <  BHT <  BHA <  ascorbic  acid.  The
HWE was less active than the positive controls. The fact that the extract
has a  lower reducing power than the controls  may be due to the lower
concentrations of electron donating constituents.
Study III
The SEs of D. moldavica demonstrated the ability to reduce
iron(III) ions. The reducing power of the extracts and positive controls
increased  in  the  order  PE  <  CH2Cl2 <  EtOAC  and n-BuOH (no
significant difference, P > 0.05) < MeOH < ACN < quercetin < ascorbic
acid  <  gallic  acid.  The  reducing  power  order  is  different  from  the
phenolic content trend estimated by the HPLC-DAD analysis. This is
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due to the fact that substances other than polyphenolic compounds
contribute to reduction of iron(III) ions.
Iron(II) chelation
The  HWE  of D. moldavica demonstrated the ability to chelate
iron(II) ions in study II. The extract was a stronger iron(II) chelator than
either ascorbic acid, BHT, BHA or Pycnogenol. EC50 values could not
be estimated for the aforementioned positive controls due to their poor
activity in this assay. However, the iron(II) chelating activity of the
extract is less than that of EDTA.
By chelating transition metals the extract demonstrated the ability to
prevent these species from participating in metal-catalysed initiation
and hydroperoxide decomposition reactions (Gordon 1990). This is
termed as a secondary antioxidant effect (Gordon 1990).
Transition metal ions have been proposed to contribute to the
oxidative damage in neurodegenerative disorders like AD (Varadarajan
et al. 2000; Bush 2003). One of the lines of treatments currently under
investigation is selective low affinity binding of transition metals,
known as metal protein attenuation (Doraiswamy 2002; Rosenberg
2003). Therefore, if the plant extract will also display mild chelating
activity in in vivo studies then it can be of therapeutic potential in the
treatment of AD.
DPPH? radical scavenging
Study II
The HWE of D. moldavica demonstrated the ability to scavenge
DPPH?. The scavenging activity of the extract and the positive controls
increased in the order of HWE < Pycnogenol and ascorbic acid (no
significant difference, P > 0.05) < BHA. The scavenging activity of the
samples in this assay can be due to either electron and/or hydrogen
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donating effects. In some cases the samples may take part in both these
kind of reactions (Magalhães et al. 2008), which may explain the reason
for the observed difference in the order of DPPH? scavenging activity
compared to iron(III) reducing power.
Study III
All  the  SEs  of D. moldavica at  a  dose  of  1  mg/mL,  with  the
exception of the PE and CH2Cl2 extracts, demonstrated the ability to
scavenge DPPH?. The scavenging activity of the extracts and the
positive controls increased in the order n-BuOH < ACN < quercetin <
MeOH < ascorbic acid and gallic acid (no significant difference, P >
0.05). All the extracts with the exception of the MeOH extract were less
active than the positive controls. The MeOH extract was a stronger
DPPH? scavenger than quercetin.
The activity of SEs in the DPPH? assay can be due to both electron
and hydrogen donating effects. Both reaction mechanisms can
contribute to the formation of hydrazine; however, iron(III) reduction
assay is based only on an electron transfer mechanism. This can be the
reason for the difference in the order of scavenging activity and iron(III)
reducing power (Magalhães et al. 2008).
ABTS?+ radical scavenging
Study II
The HWE of D. moldavica demonstrated the ability to scavenge
ABTS?+. The scavenging activity of the extract and the positive controls
at 1 minute increased in the order HWE and BHT (no significant
difference, P >  0.05)  <  ascorbic  acid  <  BHA.  The  activity  order
changed afterwards to HWE < BHT < ascorbic acid < BHA. The order
remained the same throughout the assay. This shows that BHT is slower
acting antioxidant compared to the plant extract. The activity of the
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extract and the control with the exception of BHT remained constant
and uninterrupted throughout the assay.
Study III
The  SEs  of D. moldavica demonstrated the ability to scavenge
ABTS?+ except  for  the PE and CH2Cl2 extracts. The initial scavenging
effect, t =  0,  of  the  extracts  and  the  positive  controls  increased  in  the
order n-BuOH <  ACN and  MeOH <  H2O <  EtOAc  <  ascorbic  acid  <
quercetin < gallic acid. The order of activity after 5 minutes changed to
n-BuOH < ACN < MeOH <  H2O < EtOAc < ascorbic acid < quercetin
< gallic acid. The hierarchy of activity thereafter remained the same
throughout the remaining assay run. There were gradual but significant
changes  in  the  activities  of  MeOH,  H2O, EtOAc and BuOH extracts,
however, the activity of ACN extract remained the same. This is an
indication that the former extracts are slower acting antioxidants in this
assay. Among the positive controls, it was only quercetin whose activity
continued to increase up to 15 minutes. Unlike in the DPPH? assay none
of the SEs were more effective than the positive controls. The ABTS?+
scavenging results suggest that, with the exception of PE and CH2Cl2
extracts, components present within the extracts should have the ability
to protect biological material from free radical-mediated oxidative
damage. The importance of free radical scavenging in the prevention of
oxidative stress is due to its potential therapeutic application in the
treatment of disorders such as AD. Therefore, the free radical
scavenging properties of SEs were further investigated.
Alkyl peroxyl free radical scavenging (?-carotene-linoleic acid bleaching
inhibition)
The SEs of D. moldavica demonstrated the ability to inhibit the
bleaching of ?-carotene by scavenging of ROO? radicals generated from
the thermal autoxidation of linoleic acid in study III. The scavenging
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activity of the extracts and positive controls increased in the order
MeOH < PE, CH2Cl2, n-BuOH and ACN (statistically insignificant, P >
0.05) < n-BuOH and H2O (no significant difference, P > 0.05)  < H2O
and EtOAc (no significant difference, P > 0.05) < BHA. None of the
extracts were as effective as the control.
The difference between this assay and the pervious ones are: (i) the
utilisation of a medium consisting of aqueous and lipid phases and (ii)
assessment of ROO? scavenging activity which is of physiological
relevance.
It has been proposed by some workers (Porter 1986; Frankel et al.
1994; Koleva et al. 2002) that in this assay non-polar extracts should
show higher antioxidant activity than polar extracts. This is explained in
terms of a concentrating effect of non-polar compound in the oil/water
interphase. This phenomenon is known as the polar paradox. However,
contrary to the expectations this phenomenon was not observed when
screening the SEs. This anomaly has been explained by Koleva et al.
(2003) by saying that this phenomenon is not observed in case of all
extracts.
Superoxide anion radical scavenging
The HWE of D. moldavica demonstrated the ability to scavenge
O2
?? in study II. The scavenging activity of the extract and the positive
controls increased in the order HWE < Pycnogenol < gallic acid. The
results show that the extract has O2
?- scavenging activity which can be
of potential health interest as it may be effective in reducing elevated
levels of O2
?- during oxidative stress. Oxidative stress mediated by O2
?-
is believed to be involved in the pathogenesis of AD (Valko et al. 2007;
Varadarajan et al. 2000). Therefore, O2
?- scavenging activity is
considered a relevant to AD therapy. However, there is a need to
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investigate the ability of the extract to scavenge ROS in vivo using AD
models.
Prior to the screening of the extract and control substances for O2
??
scavenging, any potential inhibitory effect they might have upon the
enzyme xanthine oxidase was determined by measuring the presence of
uric acid a byproduct of xanthine oxidase-mediated generation of O2
??.
This was to ensure that any positive effect observed for the extract or
control substances was due to O2
?? scavenging and not to the inhibition
of O2
?? formation due to xanthine oxidase inhibition. Neither the extract
nor the control substances inhibited the xanthine oxidase enzyme.
Ascorbate-iron(III)/EDTA-H2O2-catalysed 2-deoxy-D-ribose degradation
The  HWE  of D. moldavica demonstrated the ability to protect 2-
deoxy-D-ribose from oxidative degradation by scavenging HO? in study
II. The scavenging activity of the extract and the positive controls
increased in the order HWE and Pycnogenol (no significant difference,
P > 0.05) < gallic acid.
In this  assay HO? is generated by Fenton chemistry using iron(III)
ions, ascorbic acid and hydrogen peroxide. By premixing the reagents
EDTA and iron(III) together before introducing them into the reaction
mixture iron(III) ions are no longer available to attach to the 2-deoxy-D-
ribose  substrate.  As  a  result,  HO? is generated by iron(III), ascorbate
and H2O2 in “free” solution. Any damage which subsequently occurs to
the 2-deoxy-D-ribose substrate is due to a test sample’s inability to
scavenge HO? free  radicals  and  not  because  of  properties  such  as
transition metal chelation. This form of the assay is known to be non-
site specific (Hagerman et al. 1998).  The significance of this result is
that the extract has the potential to protect biological substrates e.g.
carbohydrates, proteins and DNA from deleterious effect of HO? during
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oxidative stress. HO? and other ROS are involved in the oxidative
cascade involved in pathogenesis of AD. Therefore, the HWE of D.
moldavica should be studied further  for  its  ability  to  scavenge ROS in
vivo using models simulating AD conditions.
Ascorbate-iron(III)-catalysed phospholipid degradation
The HWE of D. moldavica demonstrated the ability to protect
bovine brain-derived phospholipid liposomes from oxidative
degradation by scavenging HO? in study II. The scavenging activity of
the extract and the positive controls increased in the order gallic acid <
HWE  <  Pycnogenol  <  BHA.  The  HWE  was  less  active  compared  to
Pycnogenol and BHA, however, the extract was a stronger HO?
scavenger than the positive control gallic acid. The HO? scavenging
ability of the extract at physiological pH and its subsequent prevention
of oxidative degradation of phospholipids is of great biological
relevance. The importance of this finding can be understood in the light
of the fact that there is a high content of polyunsaturated fatty acid rich
phospholipids in the brain and HO? mediated lipid peroxidation plays a
cardinal role in the pathogenesis of neurodegenerative disorders such as
AD. Therefore, in order to investigate the therapeutic potential of the
extract’s scavenging there is need for further in vivo investigation in AD
models.
5.2. Melissa officinalis
5.2.1. Yield and Phenolic Composition
The yield of M. officinalis extract from study IV was 308.7 mg/g
and its total phenol content was estimated as 268.9 ? 21.3  mg  gallic
acid/g extract. In study IV using HPLC-PDA method C, phenolic
compounds in the extract were classified and quantified as
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hydroxycinnamic acids and flavonoids, respectively. The components
identified, in their increasing order of abundance, were m-coumaric acid
< naringin < naringenin < eriodictyol-7-O-glucoside < caffeic acid <
hesperetin < hesperidin < rosmarinic acid.
From the compounds identified, rosmarinic and caffeic acids have
already been reported to be present in M. officinalis by other researchers
(Zgórka and Glowniak 2006; Carnat et al. 1998; Ziaková and
Brandšteterova 2002, 2003). Although the remaining phenolic
components have not been reported previously, their presence in other
species of the Lamiaceae family has been confirmed (Dastmalchi et al.
2007b, 2007c; Dorman et al. 2003a, 2003b). In a number of
compositional studies reported on this plant, benzoic acid derivatives,
luteolin-7-O-glucoside and luteolin-3-O-glucuronide have been detected
(Carnat et al. 1998; Heitz et al. 2000). The absence in this sample may
be due to a variety of reasons ranging from climate and geography to
differences in the specificity of the extraction procedures used (Zgórka
and Glowniak 2006; Carnat et al. 1998; Ziaková and Brandšteterova
2002 and 2003; Heitz et al. 2000).
The total phenolic content of the extract (199.89 ? 0.41 mg/g)
determined in study IV by  HPLC-PDA  method  C  was  less  than  the
value determined by Folin-Ciocalteu method (268.9 ? 21.3 mg/g).  This
may be explained due to the limitation of the latter assay in which
interfering substances may participate in the assay.
5.2.2. Antioxidant Properties
 Iron(III) to iron(II) reduction
The plant extract demonstrated the ability to reduce iron(III) ions in
study IV. The reducing power of the extract and positive controls
increased in the order M. officinalis < BHA < quercetin < ascorbic acid
< gallic  acid.  The results  indicate  that  the reducing power of  the plant
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extract was less than those of the positive controls. This follows the
trend observed in the case of extracts of other Lamiaceae plants
(Dastmalchi et al. 2007b, 2007c; Dorman et al. 2003a, 2003b). The
reason  is  believed  to  be  that  the  positive  controls  are  present  at  much
higher concentrations than the electron donating components present in
the extract.
Iron(II) chelation
The plant extract demonstrated the ability to chelate iron(II) ions in
study IV. The extract was a better chelator of iron(II) than ascorbic
acid, gallic acid or BHA. The chelating activity of EDTA, however, was
significantly higher (P <  0.05)  than  that  of  the  plant  extract.  The
relatively mild iron(II) chelating activity of the extract is of great
significance.
By chelating transition metals the extract demonstrated the ability to
prevent these species from participating in metal-catalysed initiation
and hydroperoxide decomposition reactions (Gordon 1990). This is
termed as a secondary antioxidant effect (Gordon 1990).
The chelating activity of the extract can be of potential interest in
the food industry where transition metal ions by catalysing the initiation
and decomposition of hydroperoxides contribute to lipid oxidation
which is the main source of degradation of food products (Antolovich et
al. 2002).
 Transition metal ions have been proposed to contribute to the
oxidative damage in neurodegenerative disorders like AD (Varadarajan
et al. 2000; Bush 2003). One of the lines of treatment currently under
investigation is selective low affinity binding of transition metals,
known as metal protein attenuation (Doraiswamy 2002; Rosenberg
2003). Therefore, if the plant extract will also display mild chelating
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activity in in vivo studies, it can be of therapeutic potential in the
treatment of AD.
DPPH? free radical scavenging
The plant extract demonstrated the ability to scavenge DPPH? in
study IV. The scavenging activity of the extract and the positive
controls increased in the order M. officinalis < quercetin < caffeic acid
< gallic acid. The extract was less active than the positive controls
which may be due to the fact that antioxidant components in the extract
are present at lower concentrations compared to antioxidant positive
controls.  The  same  trend  in  DPPH? has been observed in other
Lamiaceae plants. Based on the DPPH? scavenging data, the extract
may have the ability to scavenge free radicals generated during
oxidative stress. This phenomenon is one of the pathological hallmarks
of AD. Therefore it was important to fully characterise the antioxidant
properties in other assays.
ABTS?+ free radical scavenging
 The plant extract demonstrated the ability to scavenge ABTS?+ in
study IV. The scavenging activity of the extract and the positive
controls at 1 min increased in the order M. officinalis <  quercetin  <
caffeic  acid  <  BHA  <  gallic  acid.  However,  the  order  of  activity
changed after 10 min to M. officinalis < quercetin and caffeic acid (not
significantly different, P > 0.05) < BHA < gallic acid. The scavenging
activity of the extract increased up to 30 minutes after which there was
no significant change in the activity (P > 0.05). This clearly indicates
that the extract was a slow acting free radical scavenger; however,
throughout the assay its scavenging activity was less than those of the
controls. The TEAC value calculated for M. officinalis is different from
that recently reported by Ivanova et al. (2005). The reason for the
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difference in the TEAC values can lie in the different extraction
procedures of the plant. The higher TEAC value reported for the water
infusion of the plant can be due to the higher content of phenolic
substances which have been extracted.
The ABTS?+ scavenging results suggest that the components present
within the extract should have the ability to protect biological material
from free radical-mediated oxidative damage. The importance of free
radical scavenging in the prevention of oxidative stress is due to its
potential therapeutic application in treatment of disorders such as AD.
Therefore, the free radical scavenging properties of the extract was
further investigated in different assay conditions.
Alkyl Peroxyl Free radical Scavenging (?-Carotene-linoleic Acid Bleaching
Inhibition)
The plant extract demonstrated the ability to inhibit bleaching of ?-
carotene by scavenging of ROO? radicals generated from thermal
autoxidation of linoleic acid in study IV. The scavenging activity of the
extracts and positive controls increased in the order gallic and caffeic
acids (statistically insignificant, P > 0.05) < M. officinalis, quercetin and
BHA (statistically insignificant, P > 0.05).
The strong antioxidant effect of the less polar compounds, quercetin
and BHA, and the plant extract, which is of a heterogeneous nature,
may be explained by the ‘polar paradox’ phenomenon as described by
Frankel et al. (1994). It has been proposed that less polar antioxidants
exhibit stronger antioxidant properties in oil-in-water emulsions because
they get concentrated at the oil-water interphase, thus protecting the
lipids from oxidation. On the other hand, the polar antioxidants remain
diluted in the bulk (aqueous) phase and are hence less effective in
protecting the lipids.
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The high radical scavenging activity of M. officinalis extract may be
of biological relevance as it may prevent oxidation of lipid components
such as linoleic acid within cell membranes (Liyana-Pathirana et al.
2006). Therefore, the plant extract may prove to be useful in inhibiting
progression of oxidative stress mediated pathogenesis of diseases such
as AD.
Superoxide anion radical scavenging
The plant extract demonstrated the ability to scavenge O2
?- in study
IV. The scavenging activity of the extract and the positive controls
increased in the order M. officinalis <  caffeic  acid  <  gallic  acid.
Quercetin had a poor scavenging activity and its IC50 could not be
determined. The fact that the extract is less active than the controls can
be explained in terms of the concentration of radical scavenging
constituents.
The results show that the extract has O2
?- scavenging activity which
can be of potential health interest as it may be effective in reducing the
level of O2
?- elevated during oxidative stress. O2
?--mediated oxidative
stress is believed to be involved in the pathogenesis of AD (Valko et al.
2007, Varadarajan et al. 2000). Therefore, the scavenging activity is
considered  relevant  to  AD  therapy.  However,  there  is  a  need  to
investigate the ability of the extract to scavenge ROS in vivo using AD
models.
Prior to the screening of the extract and control substances for O2
??
scavenging, any potential inhibitory effect they might have upon the
enzyme xanthine oxidase was determined by measuring the presence of
uric acid, a byproduct of xanthine oxidase-mediated generation of O2
??.
This was to ensure that any positive effect observed for the extract or
control substances was due to O2
?? scavenging and not the inhibition of
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O2
?? formation due to xanthine oxidase inhibition. Neither the extract
nor the control substances inhibited the enzyme xanthine oxidase.
Nitric oxide (NO?) radical scavenging
The plant extract demonstrated the ability to scavenge NO? in study
IV. The scavenging activity of the extract and the positive controls
increased in the order M. officinalis  < caffeic acid < gallic acid.
Quercetin did not exhibit any scavenging activity. The fact that
quercetin is not capable of scavenging physiological radicals such as
O2
?- and NO? should be studied further.
The NO? scavenging activity of the extract is of potential health
interest as it has been proposed that NO? plays an important role in the
progression of many diseases and pathological conditions such as septic
shock, atherosclerosis, ischemia reperfusion, neurodegenerative
disorders like AD, cancer and diabetes (Valko et al. 2007; Varadarajan
et al. 2000; Law et al. 2001; Moncada et al. 1991; Tamir and
Tannenbaum 1996). Therefore, this scavenging activity can also be
considered of significant relevance to AD therapy. However, as
mentioned above, the extract has to be investigated further in vivo using
AD models.
5.2.3. Acetylcholinesterase Inhibition
The plant extract demonstrated the ability to inhibit AChE in study
V. The extract and the positive control, PHY, inhibited AChE in a
similar fashion throughout the assay period. Since the inhibitory
activities of PHY and M. officinalis extracts were highest at the end of
the assay, AChE inhibition at 10 min was used as the basis for
estimation of potency. The potency of the extract at 10 min, calculated
in terms of PhE, was 1.72 ± 0.16 µg PHY/mg.
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AChE inhibition is the most widely studied and effective clinical
approach to treat the symptoms of AD (Dastmalchi et  al. 2008).
Therefore, the activity of the extract is of great relevance in AD therapy.
In addition, the extract also demonstrated a wide range of antioxidant
activities which are also considered relevant in AD therapy. Therefore,
there was a need for activity guided fractionation of the extract in order
to identify components contributing to the activity.
5.2.4. Bioactivity Guided Fractionation
The crude M. officinalis extract was fractionated into twelve
fractions (F1-F12) on a time-based scheme in study V (Table 6, Fig 1).
All fractions, with the exception of fractions F10-F12, inhibited AChE
activity. The PhE values at 10 min were used for estimating the potency
of  the  fractions.  Fractions  F2-F9  were  more  potent  than  the  crude
extract (1.72 ± 0.16 µg PHY/mg), which is indicative of the complex
nature of possible interactions amongst the compounds within the
extract. Antagonistic and synergistic effects between various
constituents within plant extracts are responsible for extracts showing
lower or higher bioactivity compared to their fractions (Dewick 1997).
Fraction F8 was identified as the most potent fraction (25.36 ± 1.63
µg PHY/mg), whilst the least potent fraction was identified as fraction
F1 (0.55 ± 0.03 µg PHY/mg). Interesting, the least potent fraction (F1)
had the highest inhibitory activity (44.35 ± 1.31 %). This shows the
importance of using PhE as opposed to percentage inhibition for
potency estimation. In calculating the former, the yield of the sample
being screened is taken into account, however, that is not the case when
estimating the latter.
The most active fraction was further analysed for its composition
using LC-DAD-ESI-MS analysis. Based on the retention characteristics,
mass and UV spectral data, the components present in fraction F8 were
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identified as apigenin-hexoside, rosmarinic acid and two rosmarinic
acid derivatives. However, there are limitations associated with this
analytical method which are (i) possible fragmentation of ions before
reaching ion trap, (ii) suppression of ionisation by the constituents
present in the plant extract and (iii) if the constituents fall outside the
chemical class for which the MS parameters have been optimised they
will  not  be detected.  Due to these limitations there is  a  need for  NMR
studies of the extract. The presence of cis- and trans-rosmarinic acid
isomers have been confirmed. Another chemical constituent present in
the fraction is suspected to be close derivatives of rosmarinic acid.
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6. CONCLUSION
Recently, there has been an exponential growth in interest in natural
antioxidants, in particular plant-derived antioxidants from aromatic,
medicinal and edible plants. The plants D. moldavica L.  and M.
officinalis L., which belong to the family Lamiaceae, have been used in
Iran because of their culinary usefulness and medicinal properties.
Therefore, extracts of the plants were screened for antioxidant
properties in a battery of in vitro assays. The plant extracts
demonstrated a wide range of antioxidant properties, some of which
were relevant to AD therapy. These results warrant further investigation
of the plant extracts for their ability to prevent oxidative stress in in vivo
models of AD. The wide spectrum of antioxidant activity of the extract
is a proof that natural antioxidants exert their effect via multiple
mechanisms.
 The compositional fingerprint analysis of the plant extracts
indicates that polyphenolic compounds present in the plants are in the
form of hydroxylated benzoic and cinnamic acid derivatives and
flavonoids. These components are proven antioxidants; therefore, it is
possible they are contributing to the activity of the extracts. However, as
seen from the ?-carotene-linoleic acid bleaching inhibition results, there
are also non-polar components which are contributing to the antioxidant
activities of the plant extracts. Rosmarinic acid was the most abundant
constituent in both the plants. This feature is shared with many
Lamiaceae plants. n-BuOH was found to be the most effective solvent
for the extraction of polyphenolic compounds from D. moldavica. The
least effective solvents were PE and CH2Cl2.
A review of the published biological, pharmacological and clinical
studies show that plant extracts traditionally used in the treatment of
cognitive dysfunction have provided novel molecular templates for
effective drugs against AD. Therefore, it can be concluded that the
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screening of plants for bioactivities relevant to AD therapy may provide
useful leads in the discovery of drugs against the disease.
Based on its ethnomedical use and recent success in a clinical study,
M. officinalis, in addition to antioxidant evaluation, was screened for
another bioactivity relevant to AD therapy, viz., AChE inhibition. The
plant extract was capable of AChE inhibition, which formed the basis of
activity guided fractionation of the crude extract.
The majority of the fractions (F1-F9) obtained from the semi-
preparative scale HPLC fractionation of the plant extracts demonstrated
AChE inhibitory activity with fractions F2-F9 proving to be
significantly (P < 0.05)  more  potent  than  the  crude  extract.  This  is  an
example of antagonism between phytochemical constituents present
within the plant extract. Fraction F8 was the most potent fraction. To
resolve the identity of the components within the fraction, it was
submitted to further analysis using LC-DAD-MS and NMR techniques,
which resulted in the elucidation of cis- and trans-rosmarinic acid
isomers.
There is a need to further investigate the efficacy of these chemical
constituents in different AD models. Compositional analysis of the
remaining potent fractions should be carried out in order to determine
the identity of their chemical constituents. Furthermore, there is a need
to investigate the possibility of a correlation existing between
antioxidant and AChE inhibitory activities.
67
7. REFERENCES
Anon, Iranian Herbal Pharmacopoeia, Ministry of Health Publication,
Tehran, 2002, 1, pp-141–121
Antolovich  M,  Prenzler  P,  Pastalides  E,  Donald  S (2002) Methods
for testing antioxidant activity. The Analyst 127, 183-198
Aruoma OI, Murcia A, Butler J, Halliwell B (1993) Evaluation of the
antioxidant and prooxidant actions of gallic acid and its
derivatives. Journal of Agricultural and Food Chemistry 41,
1880-1885.
Aruoma OI, Spencer J, Warren D, Jenner P, Butler, J, Halliwell B
(1997). Characterization of food antioxidants, illustrated using
commercial garlic and ginger preparations. Food Chemistry 60,
149–156
Aynehchi  Y,  Sormaghi  MHS,  Amin  GH,  Soltani  A,  Qumehr  N
(1982). Survey of Iranian plants for saponins, alkaloids,
flavonoids and tannins. II. International Journal of Crude Drug
Research 20, 61-70
Bartosz  G,  Janaszewska  A,  Ertel  D,  Bartosz  M (1998) Simple
determination of peroxyl radical-trapping capacity. Biochemsitry
and Molecular Biology International 46, 519-528
Beers RF, Sizer IW (1952) A spectroscopic method for measuring the
breakdown of hydrogen peroxide by catalase. Journal of Biology
Chemistry 195, 133-140
Brand-Williams W, Cuvelier ME, Berest C (1995) Use of a free
radical method to evaluate antioxidant activity. Food Science and
Technology 28, 25-30
Branen AL, Davidson PM (1997) Use of antioxidants in self-
preserving cosmetic and drug formulations. Cosmetic Science and
Technology Series 16, 159-179
68
Bush AI (2003) The metallobiology of Alzheimer’s disease. Trends in
Neuroscience 26, 207-214
Cao  G,  Alessio  HM,  Cutler  RG (1993) Oxygen-radical absorbance
capacity assay for antioxidants. Free Radical Biology and
Medicine 14, 303-311
Cao  G,  Verdon  CP,  Wu  AH,  Wang  H,  Prior  R (1995) Automated
assay of oxygen radical absorbance capacity with COBAS FARA
II. Clinical Chemistry 41, 1738-1744
Castro A, Conde S, Rodriguez-Franco MI, Martinez A (2002) Non-
cholinergic pharmacotherapy approaches to the future treatment
of Alzheimer's disease. Mini Reviews in Medicinal Chemistry 2,
37-50
Carnat  AB,  Carnat  D,  Lamaison  J-L (1998) The aromatic and
polyphenolic compositions of lemon balm (Melissa officinalis L.
Subsp. officinalis) tea. Pharmaceutica Acta Helvetiae 72, 301-
305
Carter P (1971) Spectrophotometric determination of serum iron at the
submicrogram level with a new reagent (ferrozine). Analytical
Biochemistry, 40, 405-458
Dastmalchi K, Dorman HJD, Vuorela H, Hiltunen R (2007a) Plants
as potential sources for drug development against Alzhiemr’s
disease. International Journal of Biomedical and Pharmaceutical
Sciences,1, 83-104
http://www.globalsciencebooks.info/Journals/IJBPS.html
Dastmalchi  K,  Dorman  HJD,  Ko?ar  M,  Hiltunen  R (2007b)
Chemical composition and in vitro antioxidant evaluation of a
water soluble Moldavian balm (Dracocephalum moldavica L.)
extract. Food Science and Technology 40, 239-248
Dastmalchi  K,  Dorman  HJD,  Laakso  I,  Hiltunen  R (2007c)
Chemical composition and antioxidant activity of Moldavian
69
balm (Dracocephalum moldavica L.) extracts. Food Science and
Technology 40, 1655-1663
Dastmalchi K, Dorman HJD, Oinonen PP, Darwis Y, Laakso I,
Hiltunen R (2008) Chemical composition and in vitro antioxidant
activity  of  a  lemon  balm  (Melissa officinalis L.) extract. Food
Science and Technology 41, 391-400
DeLange RJ, Glazer AN (1989) Phycoerythrin fluorescence-based
assay for peroxyl radicals: a screen for biologically relevant
protective agents. Analytical Biochemistry 28, 300-306
Dewick PM (1997) Tumor inhibitors from plants. In: Evans WC (Eds)
Trease and Evans’ Pharmacognsy, W.B. Saunders Company,
London, UK pp 409-425
Doraiswamy PM (2002) Non-Cholinergic strategies for treating and
preventing Alzheimer’s disease. CNS Drugs 16, 811-824
Dorman  HJD,  Bachmayer  O,  Ko?ar  M,  Hiltunen  R (2003a)
Antioxidant properties of aqueous extracts from selected
Lamiaceae species grown in Turkey. Journal of Agricultural and
Food Chemistry 51, 4563-4569
Dorman  HJD,  Ko?ar  M,  Kahlos  K,  Holm  Y,  Hiltunen  R (2003b)
Antioxidant properties and composition of aqueous extracts from
Mentha species, hybrids, varieties, and cultivars. Journal of
Agricultural and Food Chemistry 51, 4563-4569
Durany N, Münch G, Michel T, Riederer P (1999) Investigations on
oxidative stress and therapeutical implications in dementia.
European Archives of Psychiatry and Clinical Neuroscience 249,
S68-S73
Erel O (2004) A novel automated direct measurement method for total
antioxidant capacity using a new generation, more stable ABTS
radical cation. Clinical Biochemistry 37, 277-285
70
Ewing JF, Janero DR (1995) Micorplate superoxide dismutase
employing nonenzymatic superoxide generator Analytical
Biochemistry 232, 243-248
Ferreria A, Proença C, Serralheiro MLM, Araújo MEM (2006) The
in vitro screening for acetylcholinesterase inhibition and
antioxidant activity of medicinal plant from Portugal. Journal of
Ethnopharmacology 108, 31-37
Fillit HM (2000) The pharmacoeconomics of Alzheimer’s disease The
American Journal of Managed Care 22, S1139-S1148
Folin  O (1927) Tyrosine and tryptophan determination in proteins.
Journal of Biological Chemistry 73, 627-649
Foti  MC,  Daquino  C,  Geraci  J (2004) Electron transfer reactions of
cinnamic acids and their methyl esters with  DPPH? radical in
alcohol solutions. Journal of Organic Chemistry 69, 2309-2314
Francis PT, Palmer AM, Snape M, Wilcock GK (1999) The
cholinergic hypothesis of Alzheimer’s disease: a review of
progress. Journal of Neurology Neurosurgery an Psychiatry 66,
137-147
Frankel EN, Huang S-W, Kanner J, German JB (1994)
Interfacial phenomena in the evaluation of antioxidants: bulk oils
vs emulsions. Journal of Agricultural and Food Chemistry 42,
1054–1059
Frankel EN, Meyer AS (2000) The problems of using one-dimensional
methods to evaluate multifunctional food and biological
antioxidants Journal of the Science of Food and Agriculture 80,
1925-1941.
Fu YL, Krasnovsky CS, Foote CS (1997) Quenching of Singlet
Oxygen and Sensitized Delayed Phthalocyanine Fluorescence.
Journal of Physical Chemistry A 101, 2551-2554
71
Gohari AR, Saeidnia S, Matsuo K, Uchiyama N, Yagura T, Ito M,
Kiuchi  F,   Honda  G (2003). Flavonoid constituents of
Dracocephalum kotschyi growing in Iran and their trypanocidal
activity. Natural Medicines 57, 250-252
Gordon  M (1990) The mechanism of antioxidant action in vitro. In:
Hudson, BJF (Ed.) Food Antioxidants. Elsevier Applied Science,
London pp.1-18
Gu  HF,  Chen  RY,  Sun  YH,  Lui  F (2004) Studies on chemical
constituents from herb of Dracocephalum moldavica. Zhongguo
Zhong Yao Za Zhi 29, 232-234
Gyamfi  MA,  Yonamine  M,  Aniya  Y (1999) Free-radical scavenging
action of medicinal herbs from Ghana: Thonningia sanguinea on
experimentally-induced liver injuries. General Pharmacology 32,
661–667
Hagerman AE, Riedl KM, Jones GA, Sovik KN, Ritchard PW,
Hartzfeld  TL,  Riechel  J (1998) High molecular weight
polyphenolics (tannins) as biological antioxidants Journal of
Agricultural and Food Chemistry 46, 1887-1892
Halliwell B (2006) Reactive species and antioxidants. Redox Biology is
a fundamental theme of Aerobic life. Plant Physiology 141, 312-
322
Halliwell B, Gutterdge JMC (1995) The definition and measurement
of antioxidants in biological systems. Free Radical Biology &
Medicine 18, 125-126
Halliwell B, Gutteridge JMC, Aruoma OI (1987) The deoxyribose
method: A simple “test tube assay” for determination of rate
constants for reactions of hydroxyl radicals. Analytical
Biochemistry 165, 215-219
Haung D, Ou B, Hampsch-Woodill M, Flanagan J, Prior RL (2002)
High-throughput assay of oxygen radical absorbance capacity
72
(ORAC) using a multichannel liquid handling system coupled
with a micorplate fluorescence reader in 96- well format. Journal
of Agricultural and Food Chemistry 50, 4437-4444
Haung D, Ou B,  Prior RL (2005)  The chemistry behind antioxidant
capacity assays. Journal of Agricultural and Food Chemistry 53,
1841-1856
Heinrich M, Teoh HL (2004) Galantamine from snowdrop- the
development of a modern drug against Alzheimer’s disease from
local Caucasian knowledge. Journal of Ethnopharmacology 92,
147-162
Heitz  A,  Carnat  A,  Fraisse  D,  Carnat  A-P,  Lamaison  J-L (2000)
Luteolin 3-glucuronide, the major flavonoid from Melissa
officinalis subsp. officinalis. Fitoterapia 71, 201-202
Houghton  PJ,  Howes  M-J,  Lee  CC,  Steventon  G (2007) Uses and
abuses of in vitro tests in ethnopharmacology: Visualizing an
elephant. Journal of Ethnopharmacology 110, 391-400
Houghton PJ, Howes M-J (2005) Natural products and derivatives
affecting neurotransmissions relevant to Alzheimer’s and
Parkinson’s disease. Neurosignals 14, 6-22
Ivanova D, Gerova D, Chervenkov T, Yankova T (2005)
Polyphenols and antioxidant capacity of Bulgarian medicinal
plant. Journal of Ethnopharmacology 96, 145-150
Jones  WP,  Chin  Y-W,  Kinghorn  AD (2006) The role of
Pharmacognosy in Modern Medicine and Pharmacy. Current
Drug Targets 7, 247-264
Kakasy AZ, Lemberkovics E,  Kursinszki  L,  Janicsak G, Szoke,  E.
(2002) Data to the phytochemical evaluation of Moldavian
dragonhead (Dracocephalum moldavica L., Lamiaceae). Herba
Polonica 48, 112-119
73
Koleva II, van Beek TA, Linssen JPH, de Groot A, Evstatieva, LN
(2002) Screening of plant extracts for antioxidant activity: a
comparative study on three testing methods. Phytochemical
Analysis 13, 8-17
Koleva II, Linssen JPH, van Beek TA, Evstatieva LN, Kortenska V,
Handjieva, N (2003). Antioxidant activity screening of extracts
from Sideritis species (Labiatae) grown in Bulgaria. Journal of
the Science of Food and Agriculture 83, 809-819
Lahiri  DK,  Farlow  MR,  Sambamurti  K,  Greig  NH,  Giacobini  E,
Schneider LS (2003) A critical analysis of new molecular targets
and strategies for drug development in Alzheimer’s disease.
Current Drug Targets 4, 97-112
Laguerre M, Lecomte P, Villeneuve P (2007) Evaluation of the ability
of antioxidants to counter lipid oxidation: Existing methods, new
trends and challenges Progress in Lipid Research 46, 244-282
Law  A,  Gauthier  S,  Quirion,  R. (2001) Say NO to Alzheimer’s
disease: the putative links between nitric oxide and dementia of
the Alzheimer’s type. Brain Research  Reviews 35, 73-96
Lee J-C,  Kim H-R, Kim J,  Jang Y-S (2002) Antioxidant property of
an ethanol extract of the stem of Opuntia ficus-indica var.
saboten. Journal of Agricultural and Food Chemistry 50, 6490-
6496
Lemanska  K,  Szymusiaka  H,  Tyrakowaska  B,  Zeilinski  R,  Soffer
AEMF, Rietjens IMCM (2001) The influence of pH on
antioxidant properties and the mechanisms of antioxidant action
of hydroxyflavones. Free Radical Biology & Medicine 31, 869-
881
Liyana-Pathirana CM, Shahidi F (2006) Antioxidant properties of
commercial soft and hard winter wheats (Triticum aestivum L.)
74
and their milling fractions. Journal of the Science of Food and
Agriculture 86, 477-485
Magalhães  LM,  Segundo  MA,  Reis  S,  Lima  JLFC (2008)
Methodological aspects about in vitro evaluation of antioxidant
properties. Analytical Chemica Acta 613, 1-19
Marco GL (1968) A rapid method for evaluation of antioxidants.
Journal of the American Oil Chemists’ Society 45, 594-598
Marcocci L, Maguire JL, Droy-Lefaix MT, Packer L (1994) The
nitric oxide scavenging properties of ginkgo biloba extract Egb
761. Biochemical and Biophysical Research Communications
201, 748-755
Mason  RP,  Olmstead  EG,  Jacob  RF (2000) Antioxidant activity of
the monoamine oxidase B inhibitor Lazabemide. Biochemical
Pharmacology 60, 709-716
Miller HE (1971) A simplified method for the evaluation of
antioxidants. Journal of the American Oil Chemists’ Society 48,
91
Miller  NG,  Diplock  AT,  Rice-Evans  C,  Davis  MJ,  Gopinathan  V,
Milner A (1993) A novel method for measuring antioxidant
capacity and its application to monitoring the antioxidant status in
premature neonates. Clinical Science 84, 407-412
Moncada S, Palmer, RMJ, Higgs EA (1991) Nitric oxide: Physiology,
pathology and pharmacology. Pharmacological Reviews 43, 109-
142
Naguib YMA (2000) Antioxidant activities of astaxanthins and related
carotenoids. Journal of Agricultural and Food Chemistry 48,
1150-1154
Noruma T, Kikuchi M, Kawakami Y (1997) Proton-donative
antioxidant activity of fucoxanthin with 1,1-diphenyl-2-
75
picrylhydrazyl (DPPH). Biochemistry and Molecular Biology
International 42, 361-370
Oinonen PP, Jokela JK, Hatakka AI, Vuorela PM (2006) Linarin, a
selective acetylcholinesterase inhibitor from Mentha arvensis.
Fitoterapia 77, 429-434
Orhan  G,  Orhan  I,  ?ener  B (2006) Recent developments in natural
and synthetic drug research for Alzheimer’s disease. Letters in
Drug Design & Discovery 3, 268-274
Ou  B,  Hampsch-Woodill  M,  Prior  RL (2001) Development and
validation of an improved oxygen radical absorbance capacity
assay using fluorescein as the fluorescent probe. Journal of
Agricultural and Food Chemistry 49, 4619-4926
Oyaizu, M (1986) Studies on products of browning reaction. In:
Antioxidative activity of products of browning reaction. Japanese
Journal of Nutrition 44, 307-315
Part ED (1999) Natural antioxidants not exploited commercially. In:
Hudson BJF (Ed.) Food Antioxidants, Elsevier Applied Science,
London, pp1-18
Pazdzioch-Czochra M, Widenska A (2002) Spectrofluorimetric
determination of hydrogen peroxide scavenging activity.
Analytica Chimica Acta 452, 177-184
Pollard  SE,  Gunter  GCK,  Vauzour  D,  Vafeiadou  K,  Tzounis  X,
Whiteman M, Rice-Evans C, Spencer JPE The reaction of
flavonoid metabolites with peroxynitrite. Biochemical and
Biophysical Research Communication 350, 960-968
Porter WL (1986). Recent trends in food applications of antioxidants.
In:  Simic  MG,  Karel  M  (Eds.) Autooxidation in Food and
Biological Systems, Plenum Press, New York, pp. 295-365
Povilaityte V, Venskutonis PR (2000) Investigation of antioxidative
activity of purple peril (Perilla frutescens L.), Moldavian
76
dragonhead (Dracocephalum moldavica L.)  and  Roman
chamomile  (Anthemis nobilis L.) extracts in rapeseed oil. Journal
of the American Oil Chemists’ Society 77, 951-956
Povilaityte V, Cuvelier M-E, Berset C (2001) Antioxidant properties
of Moldavian dragonhead (Dracocephalum moldavica L.).
Journal of Food Lipids 8, 45-64
Prior  RL,  Hoang  H,  Gu  L,  Wu  X,  Bacchiocca  M,  Howard  L,
Hampsch-Woodill M, Huang D, Ou B, Jacob R (2003) Assays
for hydrophilic and lipophilic antioxidant capacity (oxygen
radical absorbance capacity (ORACFL) of plasma and other
biological and food samples. Journal of Agricultural and Food
Chemistry 51, 3273-3279
Prior  RL,  Wu  XL,  Schaich  K (2005) Standardized methods for
determination of antioxidant capacity  and phenolics in food and
dietary supplements. Journal of Agricultural and Food Chemistry
53, 4290-4302
Re R, Pellegrini N, Proteggente A, Pannala A, Yang M, Rice-Evans
C (1999) Antioxidant activity applying an improved ABTS
radical cation decolorisation assay. Free Radicals in Biology and
Medicine 26, 1231-1237
Rosenberg RN (2003) Metal chelation therapy for Alzheimer’s disease.
Archives of Neurology 60, 1678-1679
Roginsky V, Eduardo AL (2005) Review of methods to determine
chain-breaking antioxidant activity in food. Food Chemistry 92,
235-254
Saeidnia S, Gohari AR, Ito M, Kiuchi F, Honda G (2005) Bioactive
constituents from Dracocephalum subcapitatum (O. Kuntze)
Lipsky. Zeitschrift für Naturforschung C 60, 22-24
Samuelsson G (2004) Drugs of Natural Origin: A Text Book of
Pharmacognosy, Aotekarsocieteten-Swedish Pharmaceutical
77
Society, Swedish Pharmaceutical Press, Stockholm, Sweden, pp.
20
Sasaki  S,  Ohta  T,  Decker  EA (1996) Antioxidant activity of water-
soluble fractions of salmon spermary tissue. Journal of
Agricultural and Food Chemistry 44, 1682–1686
Sayre LM, Smith MA, Perry G (2001) Chemistry and biochemistry of
oxidative stress in neurodegenerative disease. Current Medicinal
Chemistry 8, 721-738
Scorer CA (2001) Preclinical and clinical challenges in the
development of disease modifying therapies for Alzheimer’s
disease. Drug Discovery Today 6, 1207-1219
Shan B, Cai YZ, Sun M, Corke H (2005) Antioxidant capacity of 26
spice extracts and charaterisation of their phenolic constituents.
Journal of Agricultural and Food Chemistry 53, 7749-7759
Shu Y-Z (1998) Recent natural products based drug development: a
pharmaceutical industry perspective. Journal of Natural Products
61, 1053-1071
Singleton  VL,  Orthofer  R,  Lamuela-Raventós  RM (1999) Analysis
of total phenols and other oxidation substrates and antioxidants by
means of Folin-Ciocalteu reagent. Methods in Enzymology 299,
152-315
Small  SA,  Mayeux  R (2005) Alzheimer’s disease and related
dementias. In: Rowland LP (Ed) Merritt’s Neurology, Lippincott
Williams & Wilkins, Philadelphia, USA, 107, pp. 771-776
Strube M, Haenen GRRM, Van den Berg H, Bast A (1997) Pitfalls
in a method for assessment of total antioxidant capacity Free
Radical Research 26, 515-521
Tamir S, Tannenbaum, SR (1996). The role of nitric oxide (NO?) in
the carcinogenic process. Biochimica & Biophysica Acta 1228,
F31-F36
78
Triantaphyllou K, Blekas, G, Boskou D (2001) Antioxidant properties
of water extracts obtained from herbs of the species Lamiaceae.
International Journal of Food Science and Nutrition 52, 313-317
Valko M, Leibfritz D, Moncol J, Cronin, MTD, Mazur M, Tesler J
(2007) Free radicals and antioxidants in normal physiological
functions and human disease. International Journal of
Biochemistry and Cellular Biology 39, 44-84
VanMiddlesworth F, Cannell RJP (1998) Dereplication and partial
identification of natural products. In: Cannell RJP (Ed) Methods
in Biotechnology 4: Natural Product Isolation, Humana Press,
Totowa, New Jersey, USA pp 291
Varadarajan  S,  Yatin  S,  Aksenova  M,  Butterfield  DA (2000)
Review: Alzheimer's amyloid ?-peptide-associated free radical
oxidative stress and neurotoxicity. Journal of Structural Biology
130, 184-208
Venkutonis  PR,  Gruzdiene  D,  Trizite  D,  Trizite  G (2005)
Assessment of antioxidant activity of plant extracts by different
methods Acta Horticulturae 677, 99-107
Vriesman MF, Haenen GRMM, Westerveld GJ, Paquay JBG, Voss
HP, Bast  A (1997) A method for measuring nitric oxide radical
scavenging activity. Scavenging properties of sulphur containg
compounds. Pharmacy World & Science 19, 283-286
Wayner DDM, Burton GM, Ingold KU, Locke S (1985) Quantitative
measurement of the total, peroxyl radical-trapping antioxidant
capability of human blood plasma by controlled peroxidation
FEBS Letters 187, 33-37
Wilkinson F,  Helman WP, Ross AB (1995) Rate constants for decay
and reactions of the lowest electronically excited single state of
molecular oxygen in solution. An expanded and revised
79
compilation. Journal of Physical and Chemical Reference Data
24, 663-1021
Zargari AI Medicinal Plants, Tehran University Press, Tehran 1990, 4,
77-81
Ziaková A, Brandšteterova E (2002) Application of different
preparation techniques for extraction of phenolic antioxidants
from lemon balm (Melissa officinalis) before HPLC analysis.
Journal of Liquid Chromatography and Related Technology 25,
3017-3032
Ziaková A, Brandšteterova, E (2003). Validation of HPLC
determination  of  phenolic acids present in some Lamiaceae
family plants. Journal of Liquid Chromatography and Related
Technology 26, 443-453
Zgórka G, Glowniak K (2006). Variation of free phenolics acid in
medicinal plants belonging to the Lamiaceae family Journal of
Pharmaceutical and Biomedical Analysis 26, 79-87
80
8. APPENDICES
Table 1. List of compound used
Compound Source
2,2?-Azinobis(3-ethylbenzothiazoline-6-
sulphonate) diammonium salt
Sigma Chemicals Co.
Acetylcholinesterase Sigma Chemicals Co.
Acetylthiocholine iodide Sigma Chemicals Co.
Acetonitrile Rathburn Chemicals Ltd.
Ascorbic acid Sigma Chemicals Co.
Apigenin Extrasynthase
Apigenin-7-O-glucoside Extrasynthase
Butylated hydroxyanisole Sigma Chemicals Co.
Butylated hydroxytoluene Sigma Chemicals Co.
Bovine serum albumin Sigma Chemicals Co.
n-Butanol Rathburn Chemicals Ltd.
Caffeic acid Extrasynthase
Chlorogenic acid Extrasynthase
m-Coumaric acid Extrasynthase
o-Coumaric acid Extrasynthase
p-Coumaric acid Extrasynthase
Dichloromethane Rathburn Chemicals Ltd.
1,1?-Diphenyl-2-picrylhydrazine Sigma Chemicals Co.
Dimethyl sulphoxide Sigma Chemicals Co.
5,5?-Dithiobis(2-nitrobenzoic Acid) Sigma Chemicals Co.
Ethylenediaminetetraacetic acid Sigma Chemicals Co.
Eriocitrin Extrasynthase
Eriodictyol Extrasynthase
Eriodictyol-7-O-glucoside Extrasynthase
Ethyl acetate Rathburn Chemicals Ltd.
Ferrozine Sigma Chemicals Co.
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Ferulic acid Extrasynthase
Folin Ciocalteu reagent Sigma Chemicals Co.
Gallic acid Sigma Chemicals Co.
Hesperetin Extrasynthase
Hesperidin Extrasynthase
Hydrogen peroxide Fluka BioChemika
p-Hydroxybenzoic acid Fluka BioChemika
Hypoxanthine Sigma Chemicals Co.
Hyperoside Extrasynthase
Iron(III) chloride Sigma Chemicals Co.
Iron(II) chloride Sigma Chemicals Co.
Isorhamnetin Extrasynthase
Isorhoifolin Extrasynthase
Kaempferol Extrasynthase
Kaempferol-7-O-glucoside Extrasynthase
Potassium hydroxide Merck
Potassium dihydrogen phosphate Merck
Linoleic acid Sigma Chemicals Co.
Luteolin Extrasynthase
Luteolin-7-O-glucoside Extrasynthase
Magnesium chloride hexahydrate Merck
Magnesium sulphate (anhyd.) Sigma Chemicals Co.
Methanol Rathburn Chemicals Ltd.
Sodium chloride Farmitalia Caro Erba
Disodium ethylenediaminetetraacetate Sigma Chemicals Co.
Sodium hydroxide Merck
Sodium dihydrogen phosphate Merck
Naringenin Extrasynthase
Naringenin-7-O-glucoside Extrasynthase
Naringin Extrasynthase
Nitroblue tetrazolium Sigma Chemicals Co.
Phsophate buffer saline tablets Sigma Chemicals Co.
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Petroleum ether Rathburn Chemicals Ltd.
Physostigmine Fluka BioChemika
Potassium peroxosulfate Sigma Chemicals Co.
Potassium hexacyanoferrate Fluka BioChemika
Pycnogenol Biolands Arômes
Quercetin Extrasynthase
Rhamnetin Extrasynthase
Rosmarinic acid Extrasynthase
Sodium carbonate Merck
TCA Sigma Chemicals Co.
TBA Sigma Chemicals Co.
TFA Fluka BioChemika
Tris HCl Sigma Chemicals Co.
Tizma base Sigma Chemicals Co.
Trolox Sigma Chemicals Co.
Tween 20 Fluka BioChemika
Vanillic acid Extrasynthase
Vitexin Extrasynthase
Xanthine oxidase Sigma Chemicals Co.
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Table 2. Mobile phase composition during method A
Time(min) (A/B) Flow Rate (mL/min)
0 100:0 1
30 80:20 1
35 80:20 1
45 50.50 1
50 10:90 1
55 100.0 1
60 100:0 1
Table 3. Mobile phase composition during method B
Time(min) (A/B/C) Flow Rate (mL/min)
0 85:15:0 0.7
15 70:30:0 0.7
18 60:40:0 0.7
30 60:40:0 0.7
35 0:100:0 0.7
37 0:85:15 0.7
48 0:70:30 0.7
63 85:15:0 0.7
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Table 4. Mobile phase composition during method C
Time(min) (A/B) Flow Rate (mL/min)
0 80:20 1
5 80:20 1
10 70:30 1
20 55.45 1
25 55:45 1
45 20:80 1
55 20:80 1
60 80:20 1
80 80:20 1
Table 5. Mobile phase composition during HPLC run
Time (min) (A/B) Flow Rate (mL/min)
0 90:10 3.5
5 90:10 3.5
15 70:30 3.5
25 57:43 3.5
37 57:43 3.5
55 20:80 3.5
57 20:80 3.5
60 90:10 3.5
72 90:10 3.5
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Table 6. Fractionation scheme
Time (min) Collection Event
4 Start
9 Stop
9 Start
14 Stop
14 Start
19 Stop
19 Start
24 Stop
24 Start
29 Stop
29 Start
34 Stop
34 Start
37 Stop
37 Start
40 Stop
40 Start
45 Stop
45 Start
50 Stop
50 Start
55 Stop
55 Start
60 Stop
60 Start
62 Stop
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Table 7. Mobile phase composition during LC-DAD-ESI-MS
Time (min) (A/B) Flow Rate (µL/min)
0 95:5 75
5 95:5 75
15 70:30 75
25 55:45 75
30 55:45 75
65 5:95 75
70 5:95 75
75 95:5 75
105 95:5 75
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 Figure 1. Semi-preparative HPLC based fractionation of the M.officinalis
extract
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